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2 SUMMARY 
 
PI-3 kinases (eg. SGK, PDK isoforms) are involved in the trafficking of membrane 
proteins, which include potassium channels (KCNQ1, Kir 4.1) and are known to be critical for 
gastric acid secretion. Stimulation of PI-3 kinase signalling could thus stimulate the acid 
secretion. Inhibition of PI-3 kinase signalling on the other hand leads to increase of cAMP 
levels which in turn could activate the cAMP dependent kinase PKA and thereby lead to 
stimulation of acid secretion. Therefore considering the significance of PI-3 kinase signalling 
in other physiological processes, there is an utmost need to clearly define its role in the 
regulation of gastric acid secretion. 
 
SGK1 is an important member of this kinase family and is known to be a potent 
stimulator of membrane KCNQ1 activity. Therefore the first aim of the study was to 
determine the role of SGK1 in regulation of gastric acid secretion. The rate of Na+ 
independent pH recovery after acid load by ammonium pulse (an indicator of H+/K+-ATPase 
activity) in the glands from SGK1 wild type and knock out mice, however, showed that rate 
of acid secretion was similar between the two genotypes under both basal and stimulated 
conditions. It indicates that lack of SGK1 does not make any difference in the regulation of 
acid secretion. Next step was to study if the overexpression of SGK1 had any effect on the 
gastric acid secretion. This was done by studying the gastric acid secretion in the mice treated 
with clinically used drugs that are known to upregulate SGK1 expression (dexamethasone and 
pioglitazone) and in the mice with defective cellular handling of ß-catenin (apcMin/+ mice), a 
condition that is known to upregulate genomic SGK1 expression.  
 
In-situ hybridisation or western blotting was employed to determine the SGK1 
expression in the stomaches from the mice. The experiments revealed an increased SGK1 
abundance in the stomaches from mice treated with dexamethsone or with pioglitazone and 
from apcMin/+ mice. The rate of H+ secretion was increased significantly in isolated glands 
from dexamethasone treated mice as compared to untreated mice. However the increase was 
significantly blunted in sgk1-/- mice, clearly demonstrating that dexamethasone induced 
gastric acid secretion is at least partially dependant on SGK1. Pioglitazone treatment also 
resulted in significant increase in rate of H+ secretion in sgk1+/+ but not in sgk1-/- mice 
suggesting that pioglitazone treatment could result in SGK1 dependant increase in gastric acid 
secretion. The rate of H+ secretion was also enhanced in the apcMin/+ mice. Further 
experiments showed that the difference between glands from treated (either with 
dexamethasone or with pioglitazone) and untreated mice of both genotypes was dissipated in 
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presence of increased local K+ concentrations pointing to the role of potassium channels. 
Similar dissipation of difference was seen in glands from apcMin/+ and apc+/+ mice in presence 
of increased local K+ concentrations. Experiments conducted by treating the glands with 
carbachol and/or forskolin also resulted in abrogation of the difference in the rate of H+  
secretion, between treated and untreated SGK1 mice of both genotypes and between both 
genotypes of APC mice, suggesting that there is no genomic upregulation of the secretory 
machinery (K+ channels). This hypothesis was further confirmed by the real time PCR 
analysis of KCNQ1 expression in the stomach. Immunoflourescence finally confirmed the 
increased membrane abundance of H+/K+-ATPase and/or KCNQ1 in the glands from 
dexamethasone or pioglitazone treated SGK1 wild type mice and in the glands from apcMin/+ 
mice. FACS analysis of the parietal cells was done additionally in APC mice to quantitatively 
demonstrate the significant increase in membrane abundance of KCNQ1 channel in apcMin/+ 
mice.  The role of SGK1 in the enhanced gastric acid secretion in apcMin/+ mice was 
established by the experiments in apcMin/+/sgk1-/- mice which showed that the increase in rate 
of H+ secretion was abolished by the additional knock out of SGK1. In conclusion, the present 
studies indicate that overexpression of SGK1 (either due to drug treatment or due to genetic 
abnormalities) can lead to increase in gastric acid secretion. 
 
The next step of this study was to elucidate the role of PI-3 kinase signalling in the 
regulation of functioning of parietal cell. Since SGK1 was already shown not to be involved 
in the regulation of basal acid secretion, a kinase above SGK1 in the signalling cascade, 
PDK1 was chosen as the candidate. Increased rate of H+ secretion was seen in glands from 
pdk1hm mice suggesting an inhibitory role of PDK1. A clear role overlap of cAMP dependent 
PKA pathway was seen in the experiments with forskolin, which did not show any additional 
increase in pdk1hm mice and with H89, which showed inhibitory effect only in pdk1hm mice. 
Involvement of other pathways was ruled out through experiments with carbachol and 
phorbol ester. In conclusion, the present study suggests the inhibitory role of PDK1 on the 
cAMP dependent PKA pathway. 
 
The present work thus demonstrates the dual role of the PI-3 kinases in the regulation 
of gastric acid secretion. On one hand upregulation of these kinases stimulates the secretion 
by increasing the membrane trafficking of secretory machinery (potassium channels and the 
proton pump) and on the other hand they inhibit the classical stimulatory pathways (PKA 
pathway) of acid secretion. The present work has identified that SGK1 is involved in the 
former effect and PDK1 in the latter effect. 
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3 ZUSAMMENFASSUNG 
 
PI-3-Kinasen sind an Membrantransportvorgängen beteiligt, die Kalium Kanäle (KCNQ1, Kir 
4.1) miteinbeziehen und entscheidend für die Magensäuresekretion sind. Eine Stimulation des 
PI-3-Kinasen Signalwegs könnte einerseits die Säuresekretion verstärken, andererseits könnte 
eine Hemmung des PI-3-Kinasen Signalwegs zu einer Erhöhung des cAMP Gehalts führen, 
welcher wiederum über Aktivierung der cAMP abhängigen Kinase PKA auch zur Stimulation 
der Säuresekretion führt. In Anbetracht der Bedeutung des PI-3-Kinasen Signalwegs in 
anderen physiologischen Prozessen, besteht ein großer Bedarf seine Rolle in der Regulation 
der Magensäure genau zu bestimmen. 
 
Die SGK1 ist ein wichtiges Mitglied dieser Kinasenfamilie und ist als ein starker 
Stimulator der KCNQ1-Aktivität in der Membran bekannt. Daher war das erste Ziel dieser 
Studie die Rolle der SGK1 in der Regulation der Magensäuresekretion zu  bestimmen. Die 
Bestimmung der Na+ unabhängigen Erholung des pH nach Säurebelastung durch 
Ammoniumpulse als Indikator der H+/K+- ATPase Aktivität zeigte, dass die Säuresekretion in 
Parietaldrüsen von SGK1-Wildtyp und Knock-out Mäusen sowohl unter basalen als auch 
stimulierten Bedingungen ähnlich war und führte zum Schluss, dass das Fehlen von SGK1 
keinen Unterschied in der Regulation der Säuresekretion macht. Der nächste Schritt war, den 
Effekt der Überexpression von SGK1 auf die Magensäuresekretion zu untersuchen. Dies 
wurde durch eine Bestimmung der Magensäuresekretion von, mit klinisch gebräuchlichen 
Medikamenten behandelten, Mäusen, die bekanntermaßen die SGK1 Expression 
hochzuregulieren steigern (Dexamethason und Pioglitazon). In diesem Zusammenhang 
wurden auch Mäuse mit dem Gen für die familiäre Adenomatosis polyposis coli (apcMin/+ 
Mäusen) untersucht, die eine Herunterregulierung von ß-catenin aufweisen, was ebenfalls die 
SGK1 genomisch hochreguliert. 
 
Die SGK1 Expression wurde mittels In-situ Hybridisierung oder Western Blots 
bestimmt. Dabei zeigte sich eine erhöhte SGK1-Expression in den Mägen von Mäusen, die 
mit Dexamethason oder mit Pioglitazon behandelt wurden, und von apcMin/+ Mäusen. Im 
Vergleich zu unbehandelten Mäusen war die Menge der H+ Sekretion in isolierten Drüsen von 
Dexamethason behandelten Mäusen signifikant erhöht, jedoch war die Erhöhung in sgk1-/- 
Mäusen signifikant abgeschwächt. Dies bewies, dass eine Dexamethason induzierte Erhöhung 
der H+ Sekretion zumindest teilweise von SGK1 abhängig ist. Eine Pioglitazonbehandlung 
bewirkte auch eine signifikante Erhöhung der H+-Sekretion in sgk+/+, aber nicht in sgk1-/- 
Mäusen, was nahe legt, dass eine Pioglitazonbehandlung SGK1-abhängige 
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Magensäuresekretion zur Folge hat. Die Menge an H+-Sekretion war auch in apcmin/+ Mäusen 
erhöht.  
 
Weitere Experimente zeigten, dass die Stimulierbarkeit (entweder mit Dexamethason 
oder Pioglitazon) in beiden Genotypen in Anwesenheit von lokal erhöhten K+- 
Konzentrationen abgeschwächt war, was auf die Rolle der Kaliumkanäle hinwies. Ähnliche 
Abschwächungen der Stimulierbarkeit wurden in Drüsen von apc Min/+ und apc +/+  Mäusen in 
Anwesenheit von lokal erhöhten K+-Konzentrationen beobachtet. Die Stimulierbarkeit durch 
Behandlung mit Carbachol und/oder Forskolin ergaben ebenfalls eine Aufhebung des 
Unterschieds in der Menge der H+-Sekretion zwischen behandelten und unbehandelten SGK1 
Mäusen beider Genotypen und zwischen beiden Genotypen von APC Mäusen, was darauf 
hindeutet, dass es dieser Effekt nicht durch genomische Hochregulation des 
Sekretionsmechanismusses zustande kommt, sondern K+-Kanäle einbezieht. Diese Annahme 
wurde durch Realtime-PCR Analyse der KCNQ1-Expression im Magen weiter bestätigt. Die 
Immunfluoreszenz bestätigte schließlich die erhöhte Menge an H+/K+ ATPase und/oder 
KCNQ1 in der Membran der Drüsen von, mit Dexamethason oder Pioglitazon behandelten, 
SGK1 Wildtypmäusen und in den Drüsen von apc Min/+ Mäusen. Eine FACS Analyse von 
Parietalzellen wurde zusätzlich bei APC Mäusen durchgeführt, um quantitativ die signifikante 
Erhöhung der Menge an KCNQ1-Kanäle in apcMin/+ Mäusen in der Membran zu 
demonstrieren. Die Rolle der SGK1 in der erhöhten Magensäuresekretion in apcMin/+ Mäusen 
wurde durch Experimente in apcMin/+sgk-/- Mäusen fundiert, die zeigten, dass die Erhöhung 
der H+ Sekretionsrate durch das zusätzliche Hemmung der SGK1 aufgehoben wurde. 
Schließlich deuten die derzeitigen Studien an, dass die Überexpression von SGK1 (entweder 
aufgrund der Medikamentenbehandlung oder durch genetische Abnormalität) zu einer 
erhöhten Magensäuresekretion führen. 
 
Der nächste Schritt dieser Studie war die Rolle des PI-3 Kinase Signalwegs in der 
Regulation der cAMP Konzentrationen in Parietalzellen aufzuklären. Da schon gezeigt wurde, 
dass SGK1 nicht an der Regulation der basalen Säuresekretion beteiligt ist, wurde PDK1, eine 
Kinase oberhalb SGK1 in der Signalkaskade, untersucht. Eine erhöhte H+ Sekretionsrate 
wurde in Drüsen von pdk1hm-Mäusen gefunden, was daraufhin deutet, dass PDK1 eine 
hemmende Funktion hat. Eine klare Aufgabenüberschneidung des cAMP-abhängigen PKA-
Signalwegs wurde in Experimenten mit Forskolin nachgewiesen, die keinen zusätzlichen 
Anstieg in pdk1hm Mäusen und mit H89 zeigte. H89 wies einen hemmenden Effekt nur in 
pdk1hm Mäusen auf. Die Beteiligung von anderen Signalwegen wurde durch Experimente 
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mit Carbachol und Phorbolester ausgeschlossen. Schlussfolgernd deutet die vorliegende 
Studie auf eine hemmende Rolle der PDK1 auf den cAMP abhängigen PKA Signalweg hin. 
 
Zusammenfassend zeigt die vorliegende Studie die Doppelrolle der PI-3-Kinasen in 
der Regulation der Magensäuresekretion. Einerseits bewirkt eine Stimulation dieser Kinasen 
die Sekretion durch eine Erhöhung des Membrantransportvorgangs (Kaliumkanäle und 
Protonenpumpe) und andererseits hemmen sie die klassischen stimulierenden Signalwege der 
Säuresekretion (PKA Signalweg). Die vorliegende Arbeit macht deutlich, dass SGK1 einen 
frühen und PDK1 einen späten Einfluss auf die Magensäuresekretion hat. 
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4 INTRODUCTION 
 
Significance 
 
Stomach plays a very important role in the digestion of food. The food that is swallowed is 
mixed, pulverised, disinfected and partly digested in the stomach. While the first two 
functions are achieved by the muscular layers, the latter two are achieved by the gastric juice 
produced by the gastric glands of stomach. Gastric juice consists of a proteolytic enzyme 
precursor ‘pepsinogen’, concentrated hydrochloric acid (HCl), mucous and water. Inactive 
pepsinogen is converted to active pepsin in presence of HCl. HCl also serves the function of 
disinfectant, since most of the harmful pathogens present in the food cannot survive in 
presence of concentrated HCl. Thus HCl forms the important constituent of the gastric juice.  
While the secretion of gastric HCl (referred to commonly as ‘gastric acid’) is physiologically 
important, concentrated HCl together with active proteolytic pepsin could also digest and 
destroy the neighbouring mucosal layer leading to the formation of ulcers. Mucous, which is 
secreted along with HCl and pepsinogen, forms a thick lining and barrier on the inner mucosa 
and protects it from the harmful effects of gastric juice. The secretion of the gastric acid, on 
other hand, is also tightly regulated and is secreted in required quantities and only in presence 
of food in the lumen (1).   
 
However, several physiological conditions like psychological stress or 
pharmacological interventions like use of steroidal/non steroidal anti-inflammatory drugs 
could lead to loss of control over the secretion of the gastric acid leading to precipitation of 
gastric or duodenal ulcers (2; 3). 
Clinically, overproduction of acid is treated by two methods: 1. by surgical removal of 
the vagus nerve innervation of stomach (vagotomy) or total removal of stomach (gastrectomy) 
2. by the use of pharmacological inhibitors of acid secretion (histamine 2 receptor antagonists 
or proton pump inhibitors) (4). However, the former method of surgical intervention has lost 
its popularity ever since the introduction of histamine 2 receptor antagonists and proton pump 
inhibitors (most importantly proton pump inhibitors) in the treatment of peptic ulcer (4-6). 
  Although pharmacological inhibition of the acid secretion by proton pump inhibitors 
has been quite effective clinically, the chronic and complete inhibition of acid secretion might 
lead to ineffective disinfection of food in stomach and defective digestion of proteins (4; 7). 
Apart from that the side effects of proton pump inhibitors have started to gain importance 
since the recent past (8). Chronic and complete inhibition of gastric acid secretion could lead 
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to increase in secretion of gastrin, a condition termed as ‘hypergastrinemia’. 
Hypergastrinemia has been reported to cause carcinoid tumors and aggravate already existing 
cancers in experimental animals (4; 9-14). There is however, no convincing evidence that 
hypergastrinemia could cause cancer in human beings, but the possibility still exists and 
cannot be ruled out completely. On the other hand studies indicate that there is a prolonged 
rebound hypersecretion with increases in both basal and maximal acid output in individuals 
who stop using proton pump inhibitors, an affect attributed to increased serum gastrin levels 
(4). Chronic suppression of acid secretion is also reported to lead to malabsorption of vitamin 
B12 and iron (4). Other potential adverse effects include enteric infections (eg, Clostridium 
difficile), community-acquired pneumonia, and hip fracture (4; 8). The reported adverse 
effects of Histamine 2 receptor antagonists are gynecomastia, mental confusion and interstitial 
nephritis (4). 
A clear understanding of the mechanisms that lead to overproduction of acid would 
thus be useful in identifying the defects in the regulatory pathways and thereby help in finding 
a safer and effective solution to the problem of gastro-intestinal ulcers. Therefore there is a 
need to study the mechanisms of gastric acid secretion, the regulatory pathways involved in 
secretion and the conditions that lead to hypersecretion of gastric acid. 
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Gastric gland (structure, location and cells involved in secretion) 
 
The internal lining (epithelium) of the stomach is in the form of tubular glands, called as 
gastric glands. Although the entire internal lining of the stomach consists of tubular glands, 
the glands located at the beginning and at the terminal portion of the stomach do not produce 
gastric acid. They mainly serve to produce the mucous and also to dilute the acid. The glands 
that are located in the middle of the stomach are the ‘true’ gastric glands, which produce the 
gastric juice (consisting of gastric acid and other enzymes). A typical gastric gland is divided 
into isthmus, neck and base (Figure 1). Isthmus consists of precursor cells, neck consists of 
mucous neck cells and parietal cells and base consists of enteroendocrine cells and chief cells. 
 
Oesophagus
Fundus 
(D-cells)
Cardia
Corpus
(Parietal cells, 
ECL cells)
Antrum (G-cells)
Duodenum
Pylorus
a b
 
 
Figure 1: Typical a. stomach and b. gastric gland indicating the location of different cells involved in the 
gastric acid secretion.  
 
Parietal cells 
 
The parietal cell is a highly specialized epithelial cell with several morphological 
characteristics that are required for its function. The cells are large and oval in shape and are 
stained deeply with eosin. They are also characterized by the presence of large number of 
mitochondria. A series of small canals (canaliculi) invaginate from the surface of the apical 
plasma membrane and project throughout the entire cell interior. The cytoplasm consists of 
membranous structures in the form of vesicles, tubules and cisternal sacs rich in H+/K+-
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ATPase (15). Upon activation, parietal cells undergo a profound morphological transition 
resulting in the fusion of the above cytoplasmic H+/K+-ATPase rich tubulovesicles with the 
apical plasma membrane (16). The fusion occurs in such a way that the H+/K+-ATPase is 
exposed into the lumen of the stomach, giving scope for the exchange of the cytoplasmic H+ 
with lumenic K+ Figure 2. Additionally various outwardly projecting potassium and chloride 
channels are also fused with the apical plasma membrane when the cell is stimulated (17-20). 
While the purpose of chloride channels is to secrete Cl- ions into lumen, potassium channels 
maintain the concentration of K+ in the vicinity of H+/K+-ATPase. 
 
α
K+
H+
H+
K+
ATP
ADP + Pi
β α
K+
H+
H+
K+
ATP
ADP + Pi Cl-
HClβ
 
 
Figure 2: Illustrative diagram showing the parietal cell canaliculus in the resting (left) and active (right) 
states (16). 
 
Enterochromaffin-like cells (ECL cells) 
 
Enterochromaffin-like cells or ECL cells are a type of enteroendocrine cells that are found 
particularly in the vicinity of parietal cells (1). They synthesize histamine and secrete it when 
stimulated by hormones (Gastrin, Acetylcholine and Pituitary adenylyl cyclase-activated 
peptide). The secreted histamine then stimulates the neighbouring parietal cells Figure 3. 
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G cells 
 
G cells are the ‘Gastrin’ secreting cells found mainly in the antrum region of the stomach. The 
vagus nerve innervates these cells. During parasympathetic stimulation, ‘gastrin-releasing 
peptide’ is released by the post-ganglionic fibers of the vagus nerve onto the G-cell that 
stimulates gastrin release Figure 3 (1).  
 
D cells 
 
D cells (delta cells) are again a type of enteroendocrine cells that secrete a hormone 
‘somatostatin’ which inhibits the G cells from producing Gastrin. They are distributed in the 
fundus, antrum and pylorus region of the stomach (1). 
 
Chief cells 
 
Chief cells are also called as ‘Zymogenic cells’ as they release a precursor enzyme 
‘Pepsinogen’. Inactive pepsinogen is converted to active pepsin in presence of acidic pH (1). 
 
Mucous producing cells 
 
Muocus producing cells, as their name suggest produce the viscous mucous that forms the 
barrier between the lumen of the stomach and the corrosive gastric acid (1). 
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Control of secretion 
 
The secretion of gastric acid is tightly regulated and is achieved by a coordinated interplay of 
neuronal and hormonal pathways (Figure 3). 
 
Neuronal 
 
Central control of the gastric acid secretion is achieved by the vagus nerve that innervates the 
stomach. The sight or smell of food could result in the release of ‘gastrin-releasing peptide’ 
from the vagal nerve endings in the stomach that stimulates the G-cells to secrete ‘gastrin’ 
which further stimulates the acid secretion. However, gastrin releasing peptide also stimulates 
the D-cells to secrete ‘somatostatin’ which indirectly inhibits the acid secretion (1). The 
secretion of gastric acid is thus, always tightly regulated and overproduction is prevented. 
 
Hormonal 
 
Endocrinal control of gastric acid secretion involves the hormones – gastrin, somatostatin and 
histamine. Gastrin is secreted from the antral G cells in response to stimulus from food intake. 
Gastrin-releasing peptide, released onto the G cells from the post ganglionic fibers of the 
vagus nerve also stimulates the secretion of gastrin. Gastrin in turn acts on the 
‘cholecystochinin type 2’ (CCK2) receptors of the ECL cells and stimulates the release of 
histamine. Both histamine and gastrin activate the parietal cell to secrete gastric acid through 
respective ‘histamine type 2’ (H2) and CCK2 receptors respectively. The acid/acidic pH in the 
lumen then stimulates the D-cells to release somatostatin, which acts on the G-cell through 
‘somatostatin receptor type 2 (SSRT2) and inhibits the gastrin release. Apart from that it also 
inhibits the release of histamine from ECL cells. Thus the ‘negative feedback control’ of acid 
secretion is achieved (1). 
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Figure 3: A schematic representation of the control of gastric acid secretion (source (13)). 
GRP – gastrin releasing peptide, SSRT2 – somatostatin receptor type 2, Ach – acetyl choline, CCK2 – 
cholecystokinin type 2 receptor, H2 – histamine type 2 receptor, ECL cell – enterochromaffin like cell. 
 
Secretory machinery 
 
H+/K+-ATPase 
 
The proton pump of stomach, hydrogen potassium ATPase (H+/K+-ATPase) is the enzyme 
primarily responsible for the acidification of the contents of stomach. It is a member of the P-
type ATPase superfamily, a large family of proteins that transports usually cations across the 
biological membranes (15; 21). It exchanges one hydrogen ion (H+) from the cytoplasm of 
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parietal cell with one potassium ion (K+) from the gastric lumen. Thus for every ‘one ion’ of 
hydrogen secreted, ‘one ion’ of potassium is retrieved (22). 
 
The H+/K+-ATPase is a heterodimeric protein, the product of two genes. The α - 
subunit of H+/K+-ATPase containing approximately 1000 amino acids is encoded by ATP4A. 
It contains the catalytic sites of the enzyme and it forms the pore through the cell membrane 
that allows the transport of ions. The ß-subunit of H+/K+-ATPase is an approximately 300 
amino acid protein with a 36 amino acid N-terminal cytoplasmic domain, a single 
transmembrane domain and a highly glycosylated extracellular domain. It is encoded by 
ATP4B. The ß-subunit stabilizes the α-subunit of the enzyme and is also required for the 
function of the enzyme (15; 21; 23). 
 
K+ channels 
 
Parietal cell H+/K+-ATPase exchanges one cytoplasmic H+ ion with one lumenic K+ ion. The 
concentration of K+ is quite low in the parietal cell canaliculus where the exchange takes 
place. Therefore the availability of K+ ions in the parietal cell canaliculus for the exchange is 
the limiting factor for the acid secretion. This is overcome by simultaneous pumping out of 
the K+ ions into the canaliculus. K+ is reportedly recycled and enters the parietal cell 
canaliculus via specific apical K+ channels (22; 24). 
 
Among the different types of K+ channels identified so far, KCNQ1 and inwardly 
rectifying K+ channels (Kir) have been suggested to serve this critical function (25-28). 
Basolateral K+ channels on the other hand that have been functionally characterized in 
isolated parietal cells of several species are thought to be essential to maintain the negative 
membrane potential essential for apical Cl- secretion (29-31). The mice lacking KCNQ1 
demonstrated loss of acid secretion and severe gastric gland hyperplasia indicating its 
significance in gastric acid secretion (25; 27; 28). The members of Kir channel family (Kir 
2.1, 4.1, 5.1, 7.1) are shown to be expressed in gastric mucosa and are believed to be involved 
in the acid secretion (32; 33). It was shown recently in isolated cultured rabbit parietal cells 
that stimulation leads to co-localization of KCNQ1 and Kir 4.1 with H+/K+-ATPase (18; 19). 
However, it is uncertain which of these channels, plays the major role in K+ efflux and a 
complete understanding of the K+ channel(s) involved is not achieved yet. 
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Cl- channels 
 
The secretion of gastric acid (HCl) from the parietal cell also requires a simultaneous 
secretion of Cl- ions into the lumen along with H+ ions. This is done by chloride channels of 
the apical membrane, which pump the cytoplasmic Cl- into the gastric lumen. The 
accumulation of Cl- ions inside the parietal cells is achieved by Cl-/HCO3- exchanger on the 
basolateral membrane which exchanges the cytoplasmic HCO3- ions with the Cl- ions of the 
blood circulation (see Figure 4). Thus secretion of gastric acid in the stomach is paralleled by 
alkalinization of the blood (34). 
 
Although it is accepted that Cl- channels play a vital role in the acid secretion, the 
exact nature and type of channels that are involved is not known. ClC2-channel was suggested 
to be the likely candidate (35; 36), but the experiments performed in the respective knockout 
mice and the studies of the localization of the channel, showed that it might not be involved 
(37). Recently a chloride transporter Slc26a9 was reported to be crucial for the gastric acid 
secretion as seen by loss of tubulovesicles in the parietal cells leading to ‘achlorhydria’ in the 
corresponding knockout mice (20). 
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Figure 4: A simplified model for the gastric acid secretion by the parietal cell. 
 
Signal transduction 
 
Pathways (gastrinergic, histaminergic, cholinergic) 
 
There are three types of activating receptors on the basolateral membrane of the parietal cell, 
i.e., histamine H2, acetylcholine M3, and gastrin CCK2. H2 receptor couples to Gs to activate 
adenylate cyclase (ACase) producing adenosine 3´, 5´-cyclic monophosphate (cAMP) and 
cAMP-dependent protein kinase (PKA) is activated. Whereas both M3 and CCK2 receptors 
couple to Gq, to activate phospholipase C (PLC) producing inositol 1,4,5-trisphosphate (IP3) 
and diacylglycerol. IP3 acts on the intracellular calcium stores and stimulates the release of 
Ca2+ while diacylglycerol activates protein kinase C (PKC) (16). The stimulation of the 
parietal cell leading to secretion of gastric acid requires the fusion of the proton pump 
containing tubulovesicles, the K+ and the Cl- channels with the apical plasma membrane. 
Therefore all the stimulatory pathways whether histaminergic, cholinergic or gastrinergic, 
lead to activation of cytoskeletal proteins and docking/fusing proteins which facilitate the 
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trafficking of the vesicles towards the membrane. Ezrin, a putative membrane-cytoskeletal 
linker phosphoprotein is the most common downstream effector among them (15; 16).  A 
simplified version of signal transduction inside the parietal cell is shown in Figure 5. 
 
CCK2 
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Gastrin HistamineAcetylcholine
PLC
Ca2+
Adenylate cyclase
(inactive)
Adenylate cyclase
(active)
ATP
cAMPPKA
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H+ K+
K+H+
Cl-
Cl-
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Figure 5: A simplified version of signal transduction inside the parietal cell.
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PI3-kinases  
 
Physiological role 
 
The PI3-kinases are a group of enzymatic proteins that were shown to be involved in the 
insulin and growth factor signalling (38). The binding of insulin to its receptor results in the 
recruitment of a lipid kinase termed PI3-kinase to the plasma membrane of the cells which 
then phosphorylates ‘phosphatidylinositol (4, 5) bisphosphate’ (PIP-2) to phosphatidylinositol 
(3, 4, 5) triphosphate (PIP-3). PIP-3 is a key messenger in the insulin signalling pathway. PIP-
3 then facilitates the phosphorylation of protein kinase B (Akt/PKB) by phosphoinositide-
dependent protein kinase-1 (PDK1) (39). Apart from Akt, PIP-3 also facilitates the 
phosphorylation of p70 ribosomal S6 kinase (S6K), and the serum and glucocorticoid induced 
protein kinase (SGK1, 2 and 3) by PDK1 (40; 41). Phosphorylation of these kinases makes 
them active and the active Akt/PKB and SGK isoforms reportedly dephosphorylate and 
inactivate the glycogen synthase kinase 3 (GSK3) (42). S6 kinase (S6K) uncouples further 
signalling cascades which are involved in biosynthesis of ribosomes and protein synthesis 
(38). Akt/PKB and SGK isoforms are involved in glucose transport by regulating the 
membrane expression of glucose transporters (GLUT, SGLT)  (40; 41; 43-45). These kinases 
are also actively involved in the mediation of other cellular activities such as proliferation, 
differentiation, chemotaxis, survival and trafficking (41; 45). 
 
Additionally insulin signalling inhibits lipid metabolism in fat cells by decreasing 
cellular concentrations of cyclic AMP in adipocytes. Akt/PKB is believed to be involved in 
this process via phosphorylation and activation of a cAMP phosphodiesterase isoform, 
PDE3B (46; 47).  
Introduction                                                                                                                   IV 
 20 
Rationale for the role in gastric acid secretion 
 
The key second messengers in the PI3-kinase pathway eg. Akt, SGK isoforms are involved in 
the trafficking of membrane proteins (40; 41; 45; 48-50). Among the proteins whose transport 
is regulated are the potassium channels (KCNQ1, Kir 4.1) (51-55). Increase in the membrane 
localization of potassium channels could at least in theory result in the increased availability 
of K+ ions on the luminal side of the parietal cells. The luminal K+ ions are then easily 
exchanged with cytoplasmic H+ ions by H+/K+-ATPase resulting in increased acid production. 
SGK1 is a potent stimulator of the K+ channel KCNQ1 (51), which is necessary for recycling 
of K+ across the apical membrane of gastric parietal cells and thus for gastric acid secretion 
(25; 28). Stimulation of PI3-kinase signalling could thus stimulate the acid secretion.  
 
Dexamethasone a known stimulator of SGK1 is also known to cause gastric ulcers. 
Although this effect is believed to be due to inhibition of cyclooxygenase and subsequent 
reduction of the local PGE2 levels in the stomach, it is also worthwhile to verify if this effect 
is mediated through SGK1. SGK1 is also upregulated by treatment with ‘peroxisome 
proliferator activated receptor γ’ agonist pioglitazone (56). Therefore it is also important to 
verify if this upregulation also leads to increased gastric acid secretion.  
 
On the other hand, the cellular cAMP levels are regulated by PI3-kinase signalling (46; 
47; 57). Inhibition of PI3-kinase signalling reportedly leads to increase of cAMP levels which 
in turn could activate the cAMP dependent kinase PKA and thereby lead to stimulation of 
acid secretion. Thus it is clear that PI3-kinase signalling is an important regulator of gastric 
acid secretion and considering its significance in other physiological processes, there is an 
utmost need to clearly define its role in the regulation of gastric acid secretion. 
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5 AIMS OF THE STUDIES   
 
The present studies were aimed at identifying the kinases involved in modulation of basal 
gastric acid secretion with a special emphasis on kinases involved in PI3-kinase pathway. The 
studies were conducted using gene targeted mice lacking the kinase under study. Known 
activators and inhibitors of the regulatory pathways of gastric acid secretion were also used as 
part of the study. 
 
The experiments were carried out with following objectives:   
 
 To identify the PI3-kinases involved in modulation of basal gastric acid secretion. 
 
 To demonstrate the role of serum and glucocorticoid inducible kinase SGK1 in 
dexamethasone induced stimulation of gastric acid secretion. 
 
 To elucidate the effect of pioglitazone treatment on the SGK1 abundance in stomach 
and to explore the subsequent effects on gastric acid secretion. 
 
 To study the gastric acid secretion in mice with defective cellular handling of ß-
catenin (apcMin/+ mice), and to explore the role of sgk1 in the regulation of acid 
secretion in these mice. 
 
 To define the role of PDK1 in the modulation of gastric acid secretion. 
 
Materials & Methods                                                                                                             VI 
 22 
6 MATERIALS 
 
Equipment 
 
Eppendorf Centrifuge 5415R    Hinz GmbH, Hamburg, Germany. 
Eppendorf Pipets 1000µl, 200µl, 20µl, 10µl  Eppendorf, Hamburg, Germany. 
Fluorescence microscope     Axiovert, Zeiss, Jena, Germany. 
Fluorescence Microscopy low lightCCD camera   Proxitronic, Bensheim, Germany. 
LSM 510 confocal microscope    Zeiss, Jena, Germany. 
Lambda 10-2 Sutter Instrument     Novato, USA. 
Lamp ebx 75 isolated     Leika, Jena, Germany. 
Light cycler      Roche Diagnostics, Mannheim, Germany. 
FACS-Calibur     Becton Dickinson, Heidelberg, Germany 
 (NIR/UV) 
MagNa Lyser       Roche Diagnostics, Mannheim, Germany 
Mastercycler gradient     Eppendorf, Hamburg, Germany. 
Metaflour Image Analyzer software   MDS Analytical Technologies, Toronto, 
Canada. 
Microflow Biological Safety Cabinet   Nalge Nunc, Wiesbaden-Bierbach, 
Germany. 
Microscope Stemi 2000     Zeiss, Jena, Germany. 
Milli-Q       MILLIPORE, S.A. Molsheim France. 
Na-Heparine disposable capillaries 
Petridishes       Greiner Bio-one, Frickenhausen, 
 Germany. 
pH Meter 765      Knick, Zweibrücken, Germany. 
Preparation material      F.S.T., Heidelberg, Germany. 
Vortex       Labnet Abimed, Langenfeld, Germany. 
 
Chemicals 
 
Amiloride      Sigma, Taufkirchen, Germany 
BaCl2x2H2O      Carl Roth, Karlsruhe, Germany. 
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BCECF      Molecular Probes, Leiden,  Netherlands 
(2’,7’,-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein) 
Buffer –formamide     Sigma, Taufkirchen, Germany. 
BSA bovine serum albumine   Sigma, Taufkirchen, Germany. 
CaCl2x2H2O      Carl Roth, Karlsruhe, Germany. 
Carbachol      Sigma, Taufkirchen, Germany 
Cell Tak adhesive    B D Biosciences, Leiden, Netherlands 
Corticosterone acetate    Sigma, Taufkirchen, Germany. 
Diethyl ether      Carl Roth, Karlsruhe, Germany. 
EDTA      Sigma, Taufkirchen, Germany. 
(Ethylenediamine tetraacetic acid) 
Ethanol absolute (99%)    Sigma, Taufkirchen, Germany. 
Forskolin      Sigma, Taufkirchen, Germany. 
Glucose      Carl Roth, Karlsruhe, Germany. 
H89       Sigma, Taufkirchen, Germany. 
HCl       Sigma, Taufkirchen, Germany. 
HEPES      Sigma, Taufkirchen, Germany. 
K2HPO4x2H20     Sigma, Taufkirchen, Germany. 
KCl       Carl Roth, Karlsruhe, Germany. 
KH2PO4      Sigma, Taufkirchen, Germany. 
Mannitol      Sigma, Taufkirchen, Germany. 
MgSO4      Sigma, Taufkirchen, Germany. 
NaCl       Sigma, Taufkirchen, Germany. 
N-Methyl-d-glucamine (NMDG)   Sigma, Taufkirchen, Germany. 
Nigericin     Sigma, Taufkirchen, Germany. 
Omeprazole      Sigma, Taufkirchen, Germany. 
PFA- Paraformaldehyde    Merck, Darmstadt, Germany. 
Phorbol ester      Sigma, Taufkirchen, Germany 
Saline 0.9%      Fresenius Kabi, Bad Homburg, Germany. 
Sterilium      Carl Roth, Karlsruhe, Germany. 
TEA buffer      Sigma, Taufkirchen, Germany. 
(triethanolamine acetic anhydride) 
Tris buffer      Sigma, Taufkirchen, Germany. 
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Kits and Antibodies 
 
Gastrin RIA kit     DiaSorin, Dietzenbach, Germany                                                           
Corticosterone ELISA kit    DRG Instruments, Marburg, Germany 
Immobilon Western kit    Millipore, Billerica, MA, USA 
DIG-labeling kit     Roche, Mannheim, Germany 
PCR purification kit     Qiagen, Hilden, Germany. 
Primer mix Search     LC, Heidelberg, Germany. 
Rabbit anti-B0AT1     Alpha Diagnostics, San Antonio, TX, USA. 
Rabbit anti-EAAC1/ EAAT3   Alpha Diagnostics, San Antonio, TX, USA. 
Rabbit anti-SIT     Alpha Diagnostics, San Antonio, TX, USA. 
RNAeasy Mini Kit     Qiagen, Hilden, Germany. 
Superscript II reverse transcriptase   Invitrogen, Karlsruhe, Germany. 
Trizol reagent     Invitrogen, Karlsruhe, Germany. 
Polyclonal goat anti-KCNQ1   C20, Santa Cruz Biotechnologies, USA 
Monoclonal mouse anti- H+/K+ ATPase Affinity bioreagents, USA 
(ß-subunit) 
Rabbit anti-mouse ß-catenin    Cell signalling, USA 
Polyclonal monospecific anti SGK1  Dr. Pineda, Berlin, Germany 
Mouse monoclonal anti-GAPDH   Sigma, Taurkirchen, Germany 
Secondary antibodies conjugated with  
alkaline phosphatase or    Promega, USA 
horse radish peroxidase   
Donkey anti-goat Alexa-488    Invitrogen, Karlsruhe, Germany 
Donkey anti-mouse Alexa-555   Invitrogen, Karlsruhe, Germany 
 
Animals  
 
All animal experiments were conducted according to the guidelines of the American 
Physiological Society and the German law for the care and welfare of animals and were 
approved by local authorities.  Age and sex matched mice of more than 3 months age were 
used for the experiments. 
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PDK1 hypomorphic mice and mice deficient in SGK1 (sgk1-/-) were obtained as 
described previously (58; 59). The mice had a mixed (C57/Bl-6-Sv129J) background. Mice 
lines were maintained by breeding the respective heterozygote males and females. Genotypes 
were determined from the samples obtained from ear or tail biopsies using standard PCR 
protocols. 
 
Mice with mutated APC (apcMin/+) and their wild type littermates (apc+/+) with a 
mixed (C57/Bl-6-Sv129J) background were generated by breeding of male apcMin/+ mice 
initially obtained from the Jackson Laboratory. Where indicated, additional mice have been 
generated by crossbreeding apcMin/+ with gene targeted mice lacking functional SGK1 (sgk1-/-) 
to generate mice carrying the mutant APC and simultaneously lacking SGK1     
(apcMin/+/sgk1-/-). 
 
Diet  
 
Mice were fed with a standard mouse diet (C1310/1314) and tap water.  
 
Standard diet C1310/1314 [0.24% Na+, 0.71% K+, 0.95% Ca2+ (wt/wt)] Altromin, Heidenau, 
Germany.  
Control diet C1000 [0.24% Na+, 0.71% K+, 0.95% Ca2+ (wt/wt)] Altromin, Heidenau, 
Germany 
 
Where indicated, control diet (C1000) was replaced with custom made pellets containing 0.2 
% w/w pioglitazone. 
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7 METHODS 
 
Intracellular pH measurement 
 
For digital imaging of cytosolic pH, isolated individual glands were incubated in a Hepes-
buffered Ringer solution containing 10 µM BCECF-AM for 15 min at 37°C. After loading, 
the chamber was flushed for 5 min with Ringer solution to remove any deesterified dye 
sticking to the outside of the glands. The perfusion chamber was mounted on the stage of an 
inverted microscope, which was used in the epifluorescence mode with a 40 X oil immersion 
objective (Figure 6). BCECF was successively excited at 490/10 and 440/10 nm, and the 
resultant fluorescent signal was monitored at 535/10 nm using an intensified charge-coupled 
device camera (Proxitronic, Germany) and specialized computer software. Between 8 and 20 
parietal cells were outlined and monitored during the course of the measurements. Intensity 
ratio data (490/440) were converted into pH values using the high-K+/nigericin calibration 
technique (60; 61). In the end of each experiment, the glands were perfused for 5 minutes 
with standard high-K+/nigericin (10µg/ml) solution (pH 7.0). The intensity ratio data thus 
obtained were converted into pH values using the rmax, rmin, pKa values previously generated 
from calibration experiments performed in isolated gastric glands to generate a standard non-
linear curve (pH range 5 to 8.5). 
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Figure 6: Flourescence microscope along with its supporting components required for the isolation of 
gastric glands and measurement of intracellular pH. 
 
Gastric H+ secretion 
 
For isolation of gastric glands, animals were fasted for 16 hours prior to experiments on wire 
grids with free access to tap water. After sacrificing the animals the stomach was removed 
and cut longitudinally. After washing with standard Hepes solution the fundic and pyloric 
regions were discarded and the gastric corpus was sliced into 0.3 cm2 sections. The tissues 
were transferred onto the cooled stage of a dissecting microscope and individual glands were 
carefully detached from the gastric wall by snapping of the tissue using sharpened 
microdissection tweezers. Care was taken not to touch the apical part of the glands. The 
glands were attached to a glass coverslip precoated with Cell-Tak adhesive. 
 
 The solutions, flow lines and perfusion chamber were maintained at 37°C by a 
thermostatically controlled heating system. The volume of the perfusion chamber was 600 µl 
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and the flow rate was 4 ml/min for all solutions. The glands were first incubated with BCECF 
for 15 minutes and then the intracellular pH recording was started. They were then loaded 
with acid by transient exposure to a solution containing 20 mM NH4Cl leading to marked 
initial alkalinization of cytosolic pH (pHi) due to entry of NH3 and binding of H+ to form 
NH4+ (62). The acidification of cytosolic pH upon removal of ammonia allowed calculating 
the mean intrinsic buffering power of the cells (62). Assuming that NH4+ and NH3 are in 
equilibrium in cytosolic and extracellular fluid and that ammonia leaves the cells as NH3: 
 
ß = ∆[NH4+]i/∆pHi,  
 
where ∆pHi is the decrease of cytosolic pH (pHi) following ammonia removal and ∆[NH4+]i is 
the decrease of cytosolic NH4+ concentration, which is identical to the concentration of 
[NH4+]i immediately before the removal of ammonia. The pK for NH4+/NH3 is 8. 9 (63) and at 
an extracellular pH (pH0) of 7.4 the NH4+ concentration in extracellular fluid ([NH4+]0) is 
19.37 [20/(1+10pHo-pK)]. The intracellular NH4+ concentration ([NH4]i) was calculated from: 
 
[NH4]i = 19.37 · 10pH0-pHi. 
 
The calculation of buffer capacity requires that NH4+ exits completely. After the initial 
decline, pHi indeed shows little further change in the absence of Na+ and presence of 
omeprazole, indicating that there is no relevant further exit of NH4+.  
 
The pH recovery in the absence of sodium is then dependent on the exchange of K+ 
ions in the physiological solution with the cytoplasmic H+ ions. The exchange and subsequent 
pH recovery is thus a direct indicator of the proton pump H+/K+ ATPase activity. To calculate 
the ∆pH/min during re-alkalinization, a manual linear fit was placed over a narrow pH range 
(pH 6.7 to 6.9) which could be applied to all measured cells.  
 
 The solutions were composed of (in mM): standard Hepes: 115 NaCl, 5 KCl, 1 CaCl2, 
1.2 MgSO4, 2 NaH2PO4, 10 glucose, 32.2 Hepes; sodium free Hepes: 132.8 NMDG, 3 KCl, 1 
CaCl2, 1.2 MgSO4, 2 KH2PO4, 32.2 Hepes, 10 mannitol, 10 glucose (for sodium free 
ammonium chloride 10 mM NMDG and mannitol were replaced with 20 mM NH4Cl); high 
K+ for calibration 105 KCl, 1 CaCl2, 1.2 MgSO4, 32.2 Hepes, 10 mannitol, 5 µM nigericin. 
The pH of the solutions was titrated to 7.4 or 7.0 with HCl/NaOH, HCl/NMDG and 
HCl/KOH, respectively, at 37°C. Where indicated the K+ concentration was increased at the 
expense of Na+/NMDG to 35 mM.  
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 Omeprazole was added into the luminal side of the parietal cells while incubating with 
BCECF. The protons released from cells activate the drug by converting it into its active 
sulfenic acid/sulfenamide derivative which is further taken up into the cell and eventually 
binds covalently to H+/K+ ATPase resulting in the irreversible inhibition of the pump. 
 
Serum gastrin 
 
To determine the serum gastrin levels, the animals were fasted overnight for 16 hours with 
free access to tap water. About 150 µl of blood specimens were withdrawn into heparinized 
hematocrit capillaries by retro-orbital puncture during light anesthesia with diethylether. Care 
was taken during the collection of blood to prevent the degradation of serum gastrin. The 
specimens were collected in ice-cold capillaries and immediately stored at -80◦C. The 
measurement was also done within 2 days after collection of the specifmen. Total serum 
gastrin concentration was determined by radio immuno assay (RIA) kit according to the 
manufacturer’s instructions. 
 
Serum corticosterone 
 
Corticosterone is the main glucocorticoid in mice; its plasma concentrations show a circadian 
rhythm with a peak 2-3 h prior to the dark cycle (64). Blood was taken from sgk1+/+ and sgk1-
/-
 mice at the beginning of the light cycle in the morning at 7 am and prior to the beginning of 
the dark cycle at 5 pm. Additionally, blood was taken from mice following a 4 day treatment 
with dexamethasone (10 µg/g BW s.c.). 
About 150 µl of blood specimens were withdrawn into heparinized hematocrit capillaries by 
retro-orbital puncture during light anesthesia with diethylether. Plasma corticosterone 
concentrations were determined using an ELISA kit according to the manufacturer´s 
instructions. 
 
Western blotting 
 
Mice were sacrificed by cervical dislocation under ether anaesthesia and the abdomen was cut 
open. The stomach was then longitudinally cut, and the lumen was cleaned with PBS. 2 ml 
lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% SDS, 1mM 
NaF, 1mM Na3VO4, ß-mercaptoethanol) containing protease inhibitor cocktail were added to 
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the tissue and homogenized for 2 min on ice. Samples were centrifuged at 20,000 g for 30 min 
and supernatants were collected. After measurement of the total protein concentration, 100 µg 
of protein were solubilized in Laemmli sample buffer at 65 ºC for 5 min and resolved by 12% 
SDS-PAGE. For immunoblotting, proteins were electro-transferred onto a nitrocellulose 
membrane and blocked in 5% nonfat milk in PBS-0.10% Tween 20 for one hour at room 
temperature. The membrane was incubated with either affinity purified rabbit anti-mouse ß-
catenin antibody (1:2000; 92 kDa), or with a polyclonal monospecific antibody against the 
SGK1 protein (1:100; 55 kDa), raised by a commercial antibody service as previously 
described (65), or with a mouse monoclonal anti-GAPDH antibody (1: 1000; 42 kDa) 
overnight at 4 °C. After washing and subsequent blocking, blots were incubated with 
secondary antibodies conjugated with alkaline phosphatase or horse radish peroxidase (goat 
anti-rabbit 1: 2000 and donkey anti-mouse 1: 10000), for 1 h at room temperature. Antibody 
binding was detected with the Immobilon Western kit with the Diana III chemiluminescence 
detection system. Bands were quantified with the Aida Image Analyzer software. 
 
In situ hybridization of SGK1 mRNA 
 
sgk1+/+ mice were treated with dexamethasone (10 µg/g BW) or vehicle (0.9% NaCl) for four 
consecutive days and were sacrificed by cervical dislocation under slight ether anaesthesia. 
The stomach was removed, immediately frozen in −25°C cold isopentane, and sliced on a 
freezing microtome at 12 µm thickness. Sections were subsequently mounted on silane-coated 
slides [2% 3-aminopropyltriethoxy-silane in acetone], dried at 60°C for 30 s, and fixed with 
4% phosphatebuffered paraformaldehyde for 20 min. After three washes with phosphate-
buffered saline (PBS; 0.1 M, pH 7.4), slides were incubated with Tris-ethylenediamine 
tetraacetic acid (EDTA) buffer (100 mM Tris and 50 mM EDTA; pH 8.0) containing 2 µg/ml 
proteinase K for 10 min at room temperature and rinsed again three times with PBS. To 
reduce nonspecific background, slides were acetylated with triethanolamine buffer (0.1 M 
triethanolamine; pH 8.0) containing 0.25% (v/v) acetic anhydride twice for 5 min. After 
prehybridization with hybridization buffer [50% formamide, 10% dextran sulfate, 5 mM 
EDTA, 20 mM Tris (pH 8.0), 10 mM dithiothreitol, 1X Denhardt’s solution, 0.05% tRNA and 
300 mM NaCl] for 1 h at 62°C, sections were incubated with fresh hybridization buffer 
containing the denatured DIG-labeled sense or antisense probe (200 ng/ml) overnight at 63°C. 
DIG-labeled, SGK1- specific, antisense and sense RNA probes were generated by in vitro 
transcription with a DIG-labeling kit. The SGK1 plasmid containing murine SGK1 sequence 
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(position 20-1373) was kindly provided by Prof (Dr). K. Klingel. For in vitro transcription, 
the plasmid was linearized with NotI (antisense probe) or with SalI (sense probe). To enhance 
the penetration into tissue sections, probes were alkalihydrolyzed to an average length of 400 
bases. After hybridization, slides were briefly rinsed in 2 X standard saline citrate (SSC) at 
room temperature and three times in 0.1 X SSC for 15 min at 63°C. Detection of the DIG-
labeled RNA probe was performed according to the protocol of the DIG nucleic acid 
detection kit. Tissues were blocked for 30 min with blocking buffer (1% blocking reagent), in 
maleic acid buffer (0.1 M maleic acid, 0.15 M NaCl; pH 7.5), and then incubated with 
alkaline phosphatase-conjugated antibody solution (anti-DIG antibody 1:2500) in blocking 
buffer containing 0.1% Triton X-100 for 1 h. After washing for four times with maleic acid 
buffer for 15 min, slides were equilibrated for 5 min in Tris buffer (0.1 M Tris, 0.1 M NaCl, 
50 mM MgCl2, pH 9.5). The color development was carried out with freshly prepared 
substrate solution [nitroblue tetrazolium salt (NBT) and 5- bromo-4-chloro-3-indolyl 
phosphate (X-phosphate); in Tris buffer]. After washing for three times with PBS, slides were 
rinsed in distilled water, dried and coverslipped with Kaiser’s gelatine solution. 
 
Immunofluorescence  
 
For immunoflourescence analysis of KCNQ1 protein abundance in the cell membrane of 
gastric glands, the animals were sacrificed by cervical dislocation under ether anethesia and 
the corpus regions of the stomach was isolated and fixed in 4% paraformaldehyde/0.1 M 
sodium phosphate buffer (pH 7.4) for two hours and then stored in PBS. After immersion in 
30% sucrose for 24 h, 15 µm cryostat sections were taken. After a brief rinse, the sections 
were incubated for 1 h in normal donkey serum with 0.3% Triton X-100. All the following 
washes and incubations were performed in PBS containing 0.3% Triton X-100 and 1% 
dimethyl sulfoxide. Without rinsing, primary polyclonal goat anti-KCNQ1 antibody (1:50) 
and mouse monoclonal anti-H+/K+-ATPase ß-sub unit (1:2000) were applied to the sections 
for 12 h at 4°C.  After three washes at 10 min, the sections were incubated with donkey anti-
goat Alexa-488 and donkey anti-mouse Alexa-555, (1:400) secondary antibodies for 1.5 h at 
room temperature. The slides were analyzed on a Zeiss LSM 510 confocal microscope 
equipped with a 40 X oil immersion objective (NA 1.3) using an argon laser at 488 and a 
He/Ne laser at 543 nm excitation sequentially with appropriate filter sets. 
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Quantitative real-time polymerase chain reaction measurements  
 
To determine the transcript levels of K+ channel KCNQ1 and SGK1, gastric tissue was 
quickly removed and frozen in liquid nitrogen. Automated disruption and homogenization of 
frozen tissue was achieved using the MagNa Lyser Instrument™. For each sample, oneway 
special tubes were filled with ceramic beads, 20–30 mg of frozen tissue and 600 µl of RLT-
buffer. Cleared cell lysate was transferred for further RNA purification. Subsequently, 1 µg of 
total RNA was reverse transcribed to complementary DNA (cDNA) utilizing the reverse 
transcription system with oligo (dT) primers according to the manufacturer’s protocol. To 
determine mRNA levels, quantitative real-time polymerase chain reaction (PCR) with the 
Light Cycler System™ was established. PCR reactions for KCNQ1 and SGK1 were 
performed in a final volume of 20 µl containing 2 µl cDNA, 2.4 µl MgCl2 (3 µM), 1 µl 
primermix (0.5 µM of both primers), 2 µl cDNA Master SybrGreen I mix, and 12.6 µl diethyl 
pyrocarbonate (DEPC)-treated water. The transcript levels of the housekeeping gene 
mGAPDH were determined in each sample using a commercial primer kit. PCR reactions for 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were performed in a final volume of 
20 µl containing 2 µl cDNA, 2 µl primer mix, 2 µl cDNA Master Sybr Green I mix, and 14 µl 
DEPC-treated water. Amplification of the target DNA was performed during 35 cycles of 
95°C for 10 s, 68°C for 10 s and 72°C for 16 s, each with a temperature transition rate of 
20°C/s and a secondary target temperature of 58°C with a step size of 0.5°C. Melting curve 
analysis was performed at 95°C 0 s, 58°C 10 s and 95°C 0 s to determine melting 
temperatures of primer dimers and the specific PCR products. Melting curve analysis 
confirmed the amplified product, which were then separated on 1.5% agarose gels to confirm 
the expected size (218 bp for KCNQ1 and 406 bp for SGK1). Finally, results were calculated 
as a ratio of the target vs house keeping gene transcripts. The following primers were used: 
 
KCNQ1 forward 5′ CCA TCA TTG ACC TCA TCGTG 3′ 
KCNQ1 reverse 5′ CCA GAA AGC CAA TGT ACAGG 3′ 
SGK1 forward: 5’-TGT CTT GGG GCT GTC CTG TAT G-3’ 
SGK1 reverse: 5’-GCT TCT GCT GCT TCC TTC ACA C-3’ 
 
Sequence analysis confirmed the amplification of PCR products of the expected gene for 
KCNQ1 (accession number NM_008434) and SGK1 (NM_011361). 
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Flow cytometric analysis (FACS) of KCNQ1 expression in the 
isolated parietal cells  
 
To isolate the parietal cells from gastric mucosa, a previously described protocol was 
modified slightly and used (66). Briefly, the mice were overnight fasted prior to experiments 
on wire grids with free access to tap water. The mice were then sacrificed and the stomach 
was cut open longitudinally. The fundic and the pyloric regions were quickly discarded and 
the gastric corpus was taken onto ice-cold standard Hepes buffer. The entire isolation 
procedure was carried out on ice (4° C). The tissue was then cleaned with standard Hepes 
buffer thoroughly and mucous was removed as much as possible. After taking the tissue into 
fresh standard Hepes buffer, the muscular layer was then separated from the mucosal layer by 
scraping with a glass slide. The scrapings were then cut into very small pieces with a stainless 
steel razor and the isolated cells were separated from the tissue debris by gradient 
centrifugation. The cell pellet that was obtained was resuspended again in standard Hepes 
buffer and the suspension was passed through stainless steel needle (35 gauge). The cells thus 
obtained were washed once with standard Hepes buffer and then incubated at 37° C for 30 
minutes first with primary polyclonal anti-goat KCNQ1 antibody, 1:100 dilution and then 
with anti-goat FITC secondary antibody, 1:1000 dilution in an atmosphere with 5 % CO2. The 
cells were washed twice and resuspended in ‘annexin winding buffer’ for flow cytometric 
analysis.  FACS analysis was performed as described. Cells were analysed by forward scatter, 
and FITC-fluorescence intensity was measured in fluorescence channel FL-1 with an 
excitation wavelength of 488 nm and an emission wavelength of 530 nm. 
 
Statistics 
 
Intracellular pH, pH recovery and buffer capacity of all parietal cells from one gland were 
averaged and the respective mean value was used for further statistical analysis. Data are 
provided as arithmetic means ± SEM, n represents the number of mice used. All data were 
tested for significance using Student´s t-test with Welch´s correction or ANOVA (Dunnets 
test), where applicable and only results with p < 0.05 were considered statistically significant. 
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8 RESULTS 
 
i. Role of SGK1 in regulation of acid secretion 
 
a. Role of SGK1 in regulation of basal and stimulated acid secretion 
 
The stomach was morphologically similar in sgk1-/- and sgk1+/+ mice. Accordingly, the 
stomach weight was similar in sgk1+/+   mice (0.23 ± 0.03 g, n = 3) and sgk1-/- mice (0.28 ± 
0.02 g, n = 3).  pH recovery following an ammonium pulse in the absence of Na+ (∆pH/min) 
which is an indicator of membrane H+/K+ ATPase activity, was measured in gastric glands 
isolated from gene targeted mice lacking SGK1 (sgk1-/-) and their wild type littermates 
(sgk1+/+).  
 
 The cytosolic pH in freshly isolated gastric glands was similar in sgk1+/+ mice (7.13 ± 
0.01, n = 6) and sgk1-/- mice (7.13 ± 0.02, n = 6).  The apparent buffer capacity was also 
similar in sgk1+/+ mice (44.9 ± 4.7 mM/pH, n = 6) and sgk1-/- mice (43.7 ± 7.3 mM/pH, n = 
6). The pH recovery following an ammonium pulse in the absence of Na+ (∆pH/min) was 
again similar in sgk1+/+ (0.027 ± 0.005, n = 6 mice, 52 cells) and sgk1-/- mice (0.030 ± 0.005, 
n = 6 mice, 68 cells) thus indicating that SGK1 is not critically important in the regulation of 
basal acid secretion (Figure 7). Addition of 100 µM omeprazole virtually abolished the Na+-
independent pH recovery to 0.006 ± 0.001 ∆pH/min (n = 3) in sgk1+/+ mice and to 0.004 ± 
0.010 ∆pH/min (n = 4) in sgk1-/- mice. 
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Figure 7: Original tracings illustrating alterations of pH in typical experiments in sgk1+/+ (left panels) and 
sgk1-/- (right panels) mice.  Alterations of cytosolic pH (∆pH) in parietal cells following an ammonium pulse. 
To load the cells with H+, 20 mM NH4Cl was added and Na+ removed (replaced by NMDG) in a first step (see 
bars below each original tracing), NH4Cl removed in a second step, Na+ added in a third step and nigericin (Nig.) 
applied in a fourth step to calibrate each individual experiment. 
 
To further study the role of SGK1 in stimulated acid secretion, the isolated gastric 
glands were stimulated with 100 µM carbachol (cholinergic pathway) or with 5 µM forskolin 
(histaminergic pathway) and the rate of pH recovery was studied.  As illustrated in Figure 8, 
both carbachol and forskolin led to a strong stimulation of gastric acid secretion (Na+-
independent pH recovery) in sgk1+/+ and sgk1-/- mice. The Na+ independent pH recovery after 
stimulation with carbachol or forskolin was, however, not significantly different between the 
genotypes. The absence of difference between genotypes when stimulated with carbachol and 
forskolin indicates that SGK1 is virtually not required in both the cholinergic and 
histaminergic stimulation of gastric acid secretion either. 
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Figure 8: Rate of Na+-independent pH recovery in glands from SGK1 mice under basal and stimulated 
conditions.  
# - indicates significant difference to respective basal/control conditions. 
 
b. Role of SGK1 in glucocorticoid induced stimulation of acid secretion 
 
To study the role of SGK1 in the glucocorticoid induced stimulation of acid secretion, sgk1+/+ 
and sgk1-/- mice were treated sub-cutaneously with dexamethasone (10 µg/g body weight) for 
four days and then gastric acid secretion was analysed in them.  
 
In situ hybridization was employed to elucidate the affect of dexamethasone treatment 
on the abundance of SGK1 mRNA in gastric tissue. As illustrated in Figure 9 dexamethasone 
enhanced the expression of SGK1 in gastric glands. 
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Figure 9: SGK1 mRNA abundance in gastric tissue of wild-type mice 
The SGK1 mRNA abundance in gastric tissue of wild type mice following a 4 day treatment with 
dexamethasone (10 µg/g BW) (B, D, DEX) or left untreated (A, C, control). No signal was obtained by using a 
sense probe (E, sense control). 
 
Plasma concentrations of corticosterone, the main glucocorticoid in mice were then 
measured. At the beginning of the light cycle in the morning at 7 am, plasma corticosterone 
concentrations were 401 ± 52 nM in sgk1+/+ and 489 ± 80 nM in sgk1-/- mice (n = 10-12 
each). There was no significant difference between both genotypes. Towards the end of the 
light cycle prior to the beginning of the dark cycle at 5 pm, plasma corticosterone 
concentrations increased significantly to 640 ± 90 nM in sgk1+/+ and to 985 ± 112 nM in  
sgk1-/- mice, respectively (n = 10-12 each). This value was significantly higher in sgk1-/- mice. 
A 4 day treatment with dexamethasone suppressed corticosterone concentrations in both 
genotypes to the same low level (87 ± 31 nM in sgk1+/+ and 91 ± 29 nM in sgk1-/- mice, n = 4-
5 each). 
 
Dexamethasone treatment did not affect the cytosolic pH of parietal cells from sgk1+/+ 
(7.15 ± 0.01 (n = 8)) and sgk1-/- (7.17 ± 0.01 (n =10)) mice, i.e. values similar to untreated 
mice and again not significantly different between both genotypes. Apart from that apparent 
buffer capacity was also not affected by treatment with dexamethasone and was similar in 
sgk1+/+ mice (46.4 ± 3.1 mM/pH, n =8) and in sgk1-/- mice (46.4 ± 2.4 mM/pH, n =10). pH 
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recovery after ammonium pulse in the absence of Na+ was however, increased significantly in 
both the genotypes but the affect was blunted in sgk1-/- mice. Treatment with dexamethasone 
led to a ~ 4 fold increase of Na+ independent realkalinization in sgk1+/+ mice (0.133 ± 0.022 
∆pH/min, n = 8) and ~ 2 fold increase in sgk1-/- mice (0.071 ± 0.012 ∆pH/min, n = 10), values 
significantly different between the two genotypes (Figure 10). Treatment of the isolated 
glands with omeprazole led to decrease of the Na+ independent pH recovery to 0.009 ± 0.003 
∆pH/min (n = 5) in sgk1+/+ mice and to 0.007 ± 0.002 ∆pH/min (n = 5) in sgk1-/- mice thus 
indicating that the stimulation by dexamethasone is dependent on the activity of H+/K+-
ATPase. 
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Figure 10: pH recovery following an ammonium pulse in parietal cells from dexamethasone treated mice 
in presence and absence of omeprazole 
a Original tracings illustrating alterations of pH in typical experiments in sgk1+/+ (left panels) and sgk1-/- (right 
panels) in untreated animals (upper panels), in animals treated with 10 µg/g BW dexamethasone for four 
consecutive days (middle panels) and in dexamethasone treated mice in the presence of 100 µM omeprazole 
(lower panels). 
b Arithmetic means ± SEM (n = 5 – 10 mice each group) of Na+ independent ∆pH in parietal cells from sgk1+/+ 
mice (open columns) and sgk1-/- mice (closed columns) treated with dexamethasone (DEX) or left untreated 
(control). ∆pH was determined in dexamethasone treated animals both, in the absence (DEX) or presence of 
omeprazole (DEX + omeprazole).  
* indicates significant difference between sgk1-/- and sgk1+/+ mice, # indicates significant difference between 
DEX treatment and control, § significant difference between omeprazole and DEX treatment to DEX treatment 
alone. 
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The experiments were then conducted under conditions that are known to enhance the 
Na+ independent pH recovery to study the effect of dexamethasone in stimulated acid 
secretion. In presence of enhanced extracellular K+ concentration (35 mM), the pH recovery 
was significantly increased in both the genotypes and the difference between the genotypes 
disappeared (Figure 11). This effect again underscores the importance of outwardly projecting 
K+ channels in the stimulation of gastric acid secretion. When the availability of K+ in the 
canaliculus is no longer a rate limiting step due to enhanced local K+ concentrations, the 
gastric acid secretion is no longer dependent on the activity of the K+ channels and thus the 
difference disappears. 
 
a
control
DEX
b
0
0.1
0.2
0.3
0.4
control DEX
∆
pH
u
n
its
/m
in
u
te
sgk1+/+
sgk1-/-
sgk1-/-sgk1+/+
7
7.5
6.5
Na+ NH4+ 35 mM K+ Na+ pH0 `7´
1 10 20
pH
u
n
its
Time (minutes)
7
7.5
6.5
1 10 20
Na+ NH4+ 35 mM K+ Na+ pH0 `7´
pH
u
n
its
Time (minutes)
Na+ NH4+ 35 mM K+ Na+ pH0 `7´
Time (minutes)
7
7.5
6.5
10 201
Na+ NH4+ 35 mM K+ Na+ pH0 `7´
7
7.5
6.5
1 2010Time (minutes)
pH
u
n
its
pH
u
n
its
∆
pH
u
n
its
/m
in
u
te
pH
u
n
its
pH
u
n
its
pH
u
n
its
pH
u
n
its
 
Figure 11: Influence of enhanced extracellular K+ concentration on pH recovery in parietal cells  
Alterations of cytosolic pH (∆pH) in parietal cells following an ammonium pulse at enhanced extracellular K+ 
concentration. 
a. Original tracings illustrating alterations of pH at enhanced extracellular K+ concentration (35 mM) in sgk1+/+ 
(left panels) and sgk1-/- (right panels) mice left untreated (upper panels) or treated with dexamethasone (lower 
panels). 
b. Arithmetic means ± SEM (n = 7 - 8 mice each group) of Na+ independent ∆pH at enhanced extracellular K+ 
concentration in parietal cells from sgk1+/+ mice (open columns) and sgk1-/- mice (closed columns) either left 
untreated (control) or treated with dexamethasone (DEX). 
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Treatment of the glands from dexamethasone treated mice additionally with carbachol 
(100 µM) and forskolin (5 µM) tended to further increase gastric acid secretion without 
reaching statistical significance (n = 4-6 each). Again, there was no significant difference 
between in sgk1+/+ and sgk1-/- mice (Figure 12). 
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Figure 12: Rate of Na+-independent pH recovery in glands from dexamethasone treated SGK1 mice under 
basal and stimulated conditions. 
* - indicates significant difference to sgk1+/+ mice. # - indicates significant difference to respective sham 
treatment (see Figure 8). § - indicates significant difference to respective basal condition. 
 
Further, real-time PCR and immunohistochemistry was applied to analyze the 
expression of the potassium channel, KCNQ1 in gastric glands from untreated and 
dexamethasone treated mice.  As shown in Figure 13, there was no difference in transcript 
levels of KCNQ1 between sgk1+/+ and sgk1-/- mice both under control conditions and after 
dexamethasone treatment thus excluding genomic upregulation of the channel due to 
dexamethasone treatment. Immunohistochemistry showed intense staining for KCNQ1 in 
both genotypes. After dexamethasone treatment, stainings for KCNQ1 showed enrichment of 
the channel at the plasma membrane. Overall, stainings tended to be stronger in 
dexamethasone treated sgk1+/+ mice (Figure 13). 
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Figure 13: Expression of the potassium channel KCNQ1 in parietal cells  
a Immunohistochemistry of isolated glands showing KCNQ1 expression in sgk1+/+ (left panels) and sgk1-/-  (right 
panels) mice following a 4 day treatment with dexamethasone (upper panels) or sham treatment (lower panels). 
b Arithmetic means ± SEM (n = number of experiments) of KCNQ1 over GAPDH transcript levels in gastric 
corpus as determined by quantitative real time PCR in sgk1+/+ (open columns) and sgk1-/- mice (closed columns) 
either sham treated (sham) or treated with dexamethasone (DEX). 
 
It is thereby evident that dexamethasone stimulated acid secretion is at least in part dependent on 
presence of SGK1. 
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c. Role of SGK1 in peroxisome proliferator activated receptor gamma 
(PPARγ) agonist mediated stimulation of acid secretion 
 
Treatement with PPARγ agonists (pioglitazone) was also reported to upregulate the expression 
of SGK1 (56). Therefore the gastric acid secretion was studied in the mice treated with 
pioglitazone.  The body weights of the mice were similar in gene targeted mice lacking serum 
and glucocorticoid inducible kinase (sgk1-/-, 31.03 ± 0.84 g, n = 6) and their wild type 
littermates (sgk1+/+, 30.21 ± 0.93 g, n = 6). A 7 day pioglitazone treatment did not lead to any 
significant increase in body weight in either sgk1+/+ mice (31.60 ± 1.02 g, n = 6) or sgk1-/- 
mice (31.90 ± 0.66 g, n = 6). Macroscopic inspection of the stomaches of sgk1-/- and sgk1+/+ 
mice did not reveal apparent morphological differences. Accordingly, the stomach weight was 
similar in sgk1+/+ mice (0.23 ± 0.03 g, n = 3) and sgk1-/- mice (0.28 ± 0.02 g, n = 3). 
Treatment with pioglitazone did not significantly alter the stomach weight in neither sgk1+/+ 
mice (0.21 ± 0.01 g, n = 3) nor sgk1-/- mice (0.24 ± 0.01 g, n = 3). According to Western 
blotting from gastric tissue, pioglitazone treatment was followed by a significant increase of 
SGK1 protein abundance (Figure 14). 
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Figure 14: SGK1 protein abundance in stomach.  
a. Original Western Blot illustrating the SGK1 (upper panel) and GAPDH (lower panel) protein abundance in 
stomach from sgk1+/+ mice without (C) and with (PIO) prior pioglitazone treatment 
b. Arithmetic means ± SEM (n = 4 mice in each group) of relative densities of SGK1 protein expression in 
stomach from sgk1+/+ mice without (C) and with (PIO) prior pioglitazone treatment. * indicates significant 
difference to absence of pioglitazone treatment (p<0.05). 
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Pioglitazone treatment also did not significantly alter cytosolic pH in sgk1+/+ mice (7.16 ± 
0.02, n = 11) and sgk1-/- mice (7.13 ± 0.02, n = 11). The apparent buffer capacity was also not 
significantly different in pioglitazone treated sgk1+/+   mice (44.4 ± 4.9 mM/pH, n = 11) and 
sgk1-/- mice (53.6 ± 5.3 mM/pH, n = 11). 
 
 As illustrated in Figure 15, pH recovery following an ammonium pulse in the absence 
of Na+ (∆pH/min) was similar in untreated sgk1+/+ and sgk1-/- mice. Pioglitazone treatment 
was followed by a marked significant increase of ∆pH/min in sgk1+/+ mice but not in sgk1-/- 
mice (Table 1, Figure 15). Accordingly, following pioglitazone treatment, ∆pH/min was 
significantly higher in sgk1+/+ mice than in sgk1-/- mice (Figure 15). Addition of omeprazole 
virtually abolished the Na+-independent pH recovery to 0.006 ± 0.001 ∆pH/min (n = 3) in 
sgk1+/+ mice and to 0.004 ± 0.010 ∆pH/min (n = 4) in sgk1-/- mice. The same low values were 
obtained in pioglitazone treated sgk1+/+ mice (0.001 ± 0.006 ∆pH/min, n = 3) and sgk1-/- mice 
(0.004 ± 0.008 ∆pH/min, n = 3). Thus, Na+-independent pH recovery required H+/K+-ATPase 
activity in untreated and pioglitazone treated sgk1+/+ and sgk1-/- mice. 
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Figure 15: Effect of pioglitazone on pH recovery following an ammonium pulse in parietal cells from 
pioglitazone treated mice in the presence and absence of omeprazole 
a. Original representative tracings illustrating alterations of pH in parietal cells from sgk1-/- (right panels) and 
sgk1+/+ (left panels) mice without treatment (upper panels), following treatment with pioglitazone for 7 days 
(middle panels) as well as following prior pioglitazone treatment and local application of omeprazole (omp) 
(lower panels).  
b. Arithmetic means ± SEM of Na+-independent alterations of cytosolic pH (∆pH/min) in parietal cells from 
sgk1+/+  (open bars) and sgk1-/- (closed bars) mice without treatment (left bars) (n = 6 mice in each group) and 
with prior pioglitazone treatment (right bars) (n = 11 mice in each group). * indicates significant difference from 
sgk1+/+ mice, § indicates significant difference from untreated mice (control) (p<0.05).  
c. Arithmetic means ± SEM (n = 3-4 mice in each group) of Na+-independent alterations of cytosolic pH 
(∆pH/min) in the presence of omeprazole (100µM) in parietal cells from sgk1+/+ (open bars) and sgk1-/- (closed 
bars) mice without treatment (left bars) and with prior pioglitazone treatment (right bars). # indicates significant 
difference from absence of omeprazole. 
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As illustrated in Figure 16, an increase in extracellular K+ concentration to 35 mM by 
replacing Na+ led to a significant increase in Na+-independent pH recovery to similarly high 
levels in sgk1+/+ and sgk1-/- mice. In the presence of 35 mM extracellular K+, the treatment 
with pioglitazone did not lead to a further increase of ∆pH/min.  Thus, enhanced extracellular 
K+ concentration dissipated the differences in H+ secretion between pioglitazone treated 
sgk1+/+  and sgk1-/- mice. 
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Figure 16: Influence of enhanced extracellular K+ concentration on pH recovery in parietal cells 
a. Original representative tracings illustrating alterations of pH at enhanced extracellular K+ concentration (35 
mM) in parietal cells from sgk1-/- (right panels) and sgk1+/+ (left panels) mice without treatment (upper panels) 
and with prior pioglitazone treatment (lower panels).  
b. Arithmetic means ± SEM (n = 4-5 mice in each group) of Na+-independent alterations of cytosolic pH 
(∆pH/min) at enhanced extracellular K+ concentration (35 mM) in parietal cells from sgk1+/+  (open bars) and 
sgk1-/- (closed bars) mice without treatment (left bars) and with prior pioglitazone treatment (right bars). # 
indicates significant difference from control physiological solution containing 3 mM K+ (refer Figure 15). 
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It was reported earlier that stimulation of the parietal cell results in trafficking of the vesicles 
containing the proton pump H+/K+-ATPase and KCNQ1 channel towards the apical 
membrane in a tubulovesicular network (18). Therefore, immunohistochemistry was 
employed to elucidate, whether pioglitazone influenced KCNQ1 and H+/K+ ATPase protein 
abundance in the cell membranes of sgk1+/+   and sgk1-/- mice. As illustrated in Figure 17a 
both the H+/K+-ATPase were diffusely distributed throughout the cytoplasm in the parietal 
cells for control treated sgk1+/+ and sgk1-/- mice. As expected, there was no difference 
between the two genotypes under control conditions. Pioglitazone treatment however, resulted 
in a clear colocalization of the channel and the pump proteins and in clustering of the 
immunoreactivities within the tubulovesicular network mostly towards the apical membrane 
in the parietal cells from sgk1+/+ mice (Figure 17 b). In contrast, in parietal cells from sgk1-/- 
mice both proteins remained in the perinuclear space. 
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Figure 17: Localization of KCNQ1 and H+/K+-ATPase in parietal cells from a. control mice, b. 
pioglitazone treated mice.Immunofluorescence of KCNQ1 (green) and H+/K+-ATPase (red) expression in 
parietal cells from sgk1-/- mice (right panels) and sgk1+/+ mice (left panels). Two different microscopic fields are 
shown for each genotype. 
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Table1: Gastric acid secretion in sham/pioglitazone treated sgk1-/- and sgk1+/+ mice under basal and stimulated 
conditions. 
 
  
  
  
pH recovery 
(∆ pH 
Units/minute) 
intracellular 
pH (units) 
buffer capacity 
(mM/pH unit) 
Number of 
mice 
Number of 
cells 
sgk1+/+ 0.027 ± 0.005 7.13 ± 0.01 44.87 ± 4.7 6 52 
sham 
sgk1-/- 0.030 ± 0.005 7.13 ± 0.02 43.66 ± 7.3 6 68 
sgk1+/+ 0.088 ± 0.012b 7.16 ± 0.02 44.37 ± 4.9 11 140 
control 
(untreated) 
pio 
sgk1-/- 0.044 ± 0.007a 7.13 ± 0.02 53.56 ± 5.3 11 160 
sgk1+/+ 0.006 ± 0.001c 7.19 ± 0.04 31.43 ± 1.5 3 52 
sham 
sgk1-/- 0.004 ± 0.010c 7.18 ± 0.03 30.05 ± 2.8 4 44 
sgk1+/+ 0.001 ± 0.006c 7.21 ± 0.02 32.57 ± 7.3 3 50 
omeprazole 
pio 
sgk1-/- 0.004 ± 0.008c 7.12 ± 0.03 44.25 ± 9.9 3 33 
sgk1+/+ 0.149 ± 0.027c 7.19 ± 0.01 32.10 ± 5.5 4 41 
sham 
sgk1-/- 0.145 ± 0.015c 7.23 ± 0.04 39.10 ± 3.8 4 53 
sgk1+/+ 0.176 ± 0.021c 7.24 ± 0.04 33.09 ± 7.8 5 45 High K
+
 
pio 
sgk1-/- 0.147 ± 0.017c 7.19 ± 0.05 46.12 ± 4.6 4 61 
 
a - indicates significant difference to wild type mice. 
b - indicates significant difference to respective sham treatment. 
c – indicates significant difference to respective basal condition. 
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d. SGK1 dependant stimulation of gastric acid secretion in mutant APC 
mice (apcMin/+) 
 
It was reported earlier that nuclear translocation of ß-catenin leads to upregulation of SGK1 
(67). The present study has thus been performed to elucidate whether gastric acid secretion is 
altered in apcMin/+ mice and if it is affected by the presence or absence of SGK1. To this end, 
gastric acid secretion was studied in isolated gastric glands from apcMin/+ mice and their wild 
type littermates (apc+/+) and then the role of SGK1 was demonstrated through studies in 
apcMin/+sgk1-/- mice. 
 
 The stomach was morphologically similar in heterozygous mice with defective APC 
(apcMin/+) and their wild type littermates (apc+/+). Accordingly, the stomach weight was 
similar in both genotypes (0.22 ± 0.01 g, n = 5 in apcMin/+ mice and 0.25 ± 0.02 g, n = 8 in 
apc+/+ mice). 
 
 The cytosolic pH in freshly isolated gastric glands (Figure 18) was similar in untreated 
apc+/+ mice (7.13 ± 0.02, n = 10) and apcMin/+ mice (7.14 ± 0.01, n = 10). The apparent buffer 
capacity was again similar in apc+/+ mice (37.7 ± 3.8 mM/pH, n = 10) and apcMin/+ mice (39.4 
± 5.2 mM/pH, n = 10).  
 
 As illustrated in Table 2, Figure 18, pH recovery following an ammonium pulse in the 
absence of Na+ was significantly (~ 2 -fold) higher in apcMin/+ mice (0.076 ± 0.010 ∆pH/min, 
n = 10) than in apc+/+ mice (0.034 ± 0.008 ∆pH/min, n = 10). Addition of 100 µM omeprazole 
decreased the Na+-independent pH recovery to 0.006 ± 0.006 ∆pH/min (n = 5) in apcMin/+ 
mice and to 0.006 ± 0.005 ∆pH/min (n = 4) in apc+/+ mice. Thus, in both genotypes, Na+-
independent pH recovery was abolished following pharmacological inhibition of H+/K+-
ATPase activity (Figure 18). 
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Figure 18: pH recovery following an ammonium pulse in parietal cells from APC mice in the presence or 
absence of omeprazole 
a. Original tracings illustrating alterations of pH in typical experiments in apcMin/+ mice (right panels) and apc+/+ 
mice (left panels) in the absence (upper panels) and presence (lower panels) of 100 µM omeprazole (OMP).  
b. Arithmetic means ± SEM of Na+-independent alterations of cytosolic pH (∆pH/min) in parietal cells from 
apcMin/+ mice (closed bars) and apc+/ + mice (open bars) in the absence (left bars) and presence (right bars) of 
omeprazole. * indicates significant difference to apc+/+ mice, # indicates significant difference to absence of 
omeprazole (control). 
  
As illustrated in Figure 19, forskolin (5 µM) led to a strong stimulation of gastric acid 
secretion in apc+/+ mice (0.209 ± 0.028 ∆pH/min, n = 7) and apcMin/+ mice (0.198 ± 0.016 
∆pH/min, n = 6). Notably, forskolin treatment increased the Na+-independent acidification 
(∆pH/min) to similar values in both genotypes. Thus, following treatment with forskolin there 
was no significant difference between apc+/+ and apcMin/+ mice.  
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Figure 19: Effects of forskolin on pH recovery in parietal cells from APC mice. 
a. Original tracings illustrating alterations of pH in typical experiments in apcMin/+ mice (right panels) and apc+/+ 
mice (left panels) in the absence (upper panels) and presence (lower panels) of forskolin (FSK, 5 µM). 
b. Arithmetic means ± SEM of Na+-independent alterations of cytosolic pH (∆pH/min) in parietal cells following 
an ammonium pulse in the absence (sham) and presence of forskolin (FSK, 5 µM) ) in apcMin/+ (closed bars) and 
apc+/+ mice (open bars). § indicates significant difference to respective sham treatment, * indicates significant 
difference to apc+/+ mice. 
 
An increase in the extracellular K+ concentration to 35 mM by replacing Na+/NMDG 
led to a significant increase in Na+-independent pH recovery to 0.259 ± 0.048 ∆pH/min (n = 
6) in apcMin/+ mice and to 0.218 ± 0.039 ∆pH/min, (n = 5) in apc+/+ mice (Figure 20). Again, 
following increase in the extracellular K+ concentration pH recovery (∆pH/min) increased to 
similar values in both genotypes. Thus, an increased extracellular K+ concentration dissipated 
the differences in H+ secretion between apc+/+ and apcMin/+ mice. 
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Figure 20: Influence of enhanced extracellular K+ concentration on pH recovery in parietal cells  
a. Original tracings illustrating alterations of pH at enhanced extracellular K+ concentration (35 mM) in apcMin/+ 
mice (right panels) and apc+/+ mice (left panels). 
b. Arithmetic means ± SEM of Na+-independent ∆pH in parietal cells from apcMin/+ mice (closed bars) and apc+/+ 
mice (open bars) at high (35 mM K+) extracellular K+ concentration. # indicates significant difference to normal 
K+ concentration (3 mM K+, control, see Figure 18). 
 
Total serum gastrin concentrations were measured to explore, whether the observed 
differences between apc+/+ and apcMin/+ parietal cells were due to differences in gastrin levels. 
Serum gastrin levels were, however, similar in apcMin/+ mice (35.6 ± 2.4 pM/L, n = 8) and 
apc+/+ mice (36.3 ± 1.8 pM/L, n = 15).  
 
 Western blotting was performed to elucidate, whether the functional differences 
between  apc+/+ and apcMin/+ parietal cells could have been related to differences in protein 
abundance of ß-catenin and/or SGK1. As illustrated in Figure 21, the protein abundance for 
both, ß-catenin and SGK1 was indeed significantly larger in apcMin/+ than in apc+/+ mice. 
Quantitative real time PCR analysis further revealed significantly higher expression of SGK1 
in apcMin/+ mice (50.0 ± 6.0 copies/GAPDH X 1000, n = 9) as compared to apc+/+ mice (31.7 
± 4.6 copies/GAPDH X 1000, n = 11). 
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Figure 21: ß-catenin and SGK1 protein abundance in gastric glands.  
a. Original Western Blot illustrating the ß-catenin (upper panel) and GAPDH (lower panel) protein abundance in 
apcMin/+ mice and apc+/+ mice. 
b. Arithmetic means ± SEM of relative densities of ß-catenin protein expression in stomach from apcMin/+ mice 
(closed bars) and apc+/+ mice (open bars). * indicates significant difference between apcMin/+ and apc+/+ mice 
(p<0.05). 
c. Original Western Blot illustrating the SGK1 (upper panel) and GAPDH (lower panel) protein abundance in 
apcMin/+ mice and apc+/+ mice.  
d. Arithmetic means ± SEM of relative densities of SGK1 protein expression in stomach from apcMin/+ mice 
(closed bars) and apc+/+ mice (open bars). * indicates significant difference between apcMin/+ and apc+/+ mice. 
 
Immunohistochemistry and real time PCR analysis were performed to elucidate, 
whether the enhanced expression of ß-catenin and SGK1 influenced KCNQ1 transcription, 
expression or protein abundance in the cell membranes of apcMin/+ mice. According to real 
time PCR, KCNQ1 transcript levels in the gastric glands were not significantly different 
between apc+/+ (2.7 ± 0.5 copies/GAPDH X 1000, n = 9) and apcMin/+ (3.3 ± 0.4 
copies/GAPDH X 1000, n = 9) mice. As shown in Figure 22, the total KCNQ1 protein 
Results                                                                                                                                  VIII 
 55 
abundance was again similar in apc+/+ and apcMin/+ parietal cells. The localization of the 
protein was however, visibly different between the genotypes. In the parietal cells from 
apc+/+, KCNQ1 was diffusely distributed throughout the cytoplasm, whereas in the parietal 
cells from apcMin/+ the protein was seen to be localized towards the plasma membrane. 
 
 To quantitatively analyze the membrane abundance of KCNQ1, the parietal cells were 
isolated, stained and analyzed in FACS. As shown in the Figure 22, the KCNQ1 abundance in 
the cell membrane was significantly larger in apcMin/+ than in apc+/+ parietal cells. 
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Figure 22: Cell membrane KCNQ1 protein expression in parietal cells  
a. Immunofluorescence of KCNQ1 expression in parietal cells from apcMin/+ mice (right panels) and apc+/+ mice 
(left panels). Antibodies are directed against KCNQ1 (green fluorescence). Three different microscopic fields are 
shown for each genotype.  
b. Representative histogram from Flow cytometric (FACS) analysis of the membrane KCNQ1 expression in 
isolated parietal cells.  
c. Arithmetic means ± SEM of the percentage of gated cells (corrected to control) from apcMin/+mice (closed bar) 
and  apc+/+ mice (open bar). * indicates significant difference between apcMin/+ and apc+/+ mice (p<0.05). 
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To explore, whether the stimulation of H+ secretion in apcMin/+ mice indeed required the 
presence of SGK1, additional experiments were performed in mice carrying the mutant APC 
and at the same time lacking functional SGK1 (apcMin/+/sgk1-/-). Comparison was made to 
both, apc+/+/sgk1+/+ and apcMin/+/sgk1+/+ littermates. As illustrated in Figure 23, the enhanced 
H+ secretion in apcMin/+ mice was absent in mice lacking SGK1 (apcMin/+/sgk1-/- ).   The rate 
of pH recovery in apcMin/+/sgk1-/- (0.043 ± 0.008 ∆pH/min, n = 10) was not significantly 
different from that of apc+/+/sgk1+/+ (0.034 ± 0.008 ∆pH/min, n = 10) mice, but significantly 
smaller than that of apcMin/+/sgk1+/+ (0.076 ± 0.009 ∆pH/min, n = 10) mice. 
 
6
6.5
7
7.5
1 10 20 30
6
6.5
7
7.5
1 10 20 30 40
pH0 `7´Na+`0´ Na+NH4+Na+
apcMin/+ sgk1+/+ apcMin/+ sgk1-/-
0.00
0.02
0.04
0.06
0.08
0.10
∆
pH
u
n
its
/ m
in *
#
a.
pH
u
n
its
Time (minutes)
pH
u
n
its
Time (minutes)
apc+/+ sgk1+/+
apcMin/+ sgk1+/+
apcMin/+ sgk1-/-
b.
pH0 `7´Na+`0´ Na+NH4+Na+
∆
pH
u
n
its
/ m
in
pH
u
n
its
pH
u
n
its
 
 
Figure 23: SGK1 requirement for accelerated pH recovery in parietal cells from APC-deficient mice 
a. Original tracings illustrating alterations of pH in typical experiments in apcMin/+/sgk1+/+ mice (left panel) and 
apc+/+/sgk1-/- mice (right panel).  
b. Arithmetic means ± SEM of Na+-independent alterations of cytosolic pH (∆pH/min) in parietal cells from 
apc+/+/sgk1+/+ mice (open bar) apcMin/+/sgk1+/+ mice (closed bar) and apcMin/+/sgk1-/- mice (hatched bar). * 
indicates significant difference to apc+/+/sgk1+/+ mice, # indicates significant difference to apcMin/+/sgk1+/+ mice. 
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Table 2: Effect of stimulators and inhibitors of gastric acid secretion on the rate of pH recovery, 
intracellular pH and buffer capacity in isolated gastric glands from apc mice. 
 
  
Rate of pH 
recovery (∆ pH 
units/minute) 
Initial pH 
(Units) 
Buffer capacity 
(mM/pH unit) 
Number 
of mice 
Number 
of cells 
apc+/+ 0.034 ± 0.008 7.13 ± 0.02 37.66 ± 3.8 10 115 
apcMin/+ 0.076 ± 0.010a 7.15 ± 0.01 39.38 ± 5.2 10 122 
Untreated 
(control) 
apcMin/+/sgk1-/- 0.043 ± 0.008b 7.19 ± 0.05 35.9 ± 5.2 10 140 
apc+/+ 0.031 ± 0.009 7.08 ± 0.04 28.67 ± 6.3 3 32 0.1 % DMSO 
(sham) apcMin/+ 0.124 ± 0.024a 7.14 ± 0.04 27.35 ± 6.4 4 36 
apc+/+ 0.006 ± 0.006c 7.12 ± 0.01 42.58 ± 3.9 5 87 Omeprazole 
apcMin/+ 0.006 ± 0.005c 7.14 ± 0.01 44.66 ± 4.9 4 60 
apc+/+ 0.218 ± 0.039c 7.20 ± 0.06 30.17 ± 6.1 5 73 35mM K+ 
apcMin/+ 0.259 ± 0.048c 7.19 ± 0.02 37.52 ± 2.0 6 82 
apc+/+ 0.209 ± 0.028d 7.19 ± 0.05 37.61 ± 5.9 7 84 Forskolin 
apcMin/+ 0.198 ± 0.016d 7.31 ± 0.06d 33.38 ± 4.2 6 70 
 
a - significant difference with respect to apc+/+ mice. 
b – significant difference with respect to apcMin/+ mice 
c - significant difference to respective control treatment. 
d - significant difference to respective sham treatment. 
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ii. Role of PDK1 in regulation of acid secretion 
 
To study the role of PDK1 in regulation of acid secretion, pH recovery following an 
ammonium pulse in the absence of Na+ (∆pH/min) was measured in gastric glands isolated 
from gene targeted mice expressing only 20 % of PDK1 gene (pdk1hm) and their wild type 
littermates (pdk1wt). As reported previously, the PDK1 hypomorphic mice (pdk1hm) were 
smaller (22.5 ± 0.9 g, n = 12) than their wild type littermates (pdk1wt, b.w. 32.7 ± 1.3 g, n = 
12) (68). Food and fluid intake were similar in both genotypes (68). 
In isolated gastric glands, cytosolic pH and buffer capacity, determined by utilizing 
BCECF-fluorescence, was similar in pdk1hm and in pdk1wt mice (Table 3, Figure 24). 
Accordingly, Na+-independent pH recovery following an ammonium pulse (∆pH/min) was 
significantly (~ 2.5-fold) faster in pdk1hm than in pdk1wt mice. As shown in Figure 24, H+/K+-
ATPase inhibitor omeprazole (100 µM) virtually abolished the pH recovery in both 
genotypes.  
 
 Fasting serum gastrin levels were measured to verify if the increased acid secretion is 
due to increased serum gastrin. Serum gastrin levels were similar in pdk1hm mice (39.5 ± 3.8 
pM, n = 3 mice) and in pdk1wt mice (39.9 ± 3.4 pM, n = 3 mice). 
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Figure 24:  pH recovery following an ammonium pulse in parietal cells from PDK1 mice in presence and 
absence of omeprazole 
a. Original tracings illustrating alterations of pH in typical experiments in pdk1wt mice (left panels) and pdk1hm 
mice (right panels) in the absence (upper panels) and presence (lower panels) of 100 µM omeprazole.  
b. Arithmetic means ± SEM of Na+ independent alterations of cytosolic pH (∆pH/min) in parietal cells from 
pdk1hm mice (closed bars) and pdk1wt mice (open bars) in the absence (left bars) and presence (right bars) of 100 
µM omeprazole. * indicates significant difference between pdk1hm mice and pdk1wt mice, # indicates significant 
difference between absence (control) and presence of omeprazole. 
 
To identify the specific pathway responsible for the increased acid secretion, the 
isolated gastric glands from the mice were treated with known stimulators and inhibitors of 
acid secretion and the rate of H+ ion secretion was studied. As shown in Table 3, both the 
intracellular pH and buffer capacity were not affected by different experimental conditions. 
 
To explore the role of potassium (channels) in the increased rate of H+ ion secretion in 
pdk1hm mice, pH recovery was studied under enhanced local K+ concentrations.  An increase 
of local K+ concentrations to 35 mM (replacing Na+/NMDG) increased ∆pH/min to similar 
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values in pdk1hm and pdk1wt mice (Figure 25). The glands from pdk1wt mice showed a faster 
recovery in presence of increased extracellular K+ as compared to glands from pdk1hm mice. 
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Figure 25: Influence of enhanced extracellular K+ concentration on pH recovery in parietal cells  
a. Original tracings illustrating alterations of pH at enhanced extracellular K+ concentration (35 mM) in pdk1wt 
mice (left panels) and pdk1hm mice (right panels). 
b. Arithmetic means ± SEM of Na+ independent ∆pH at enhanced (35 mM) extracellular K+ concentration in 
parietal cells from pdk1hm mice (closed bars) and pdk1wt mice (open bars). # indicates significant difference 
between high or low K+ (control, see Figure 24) concentration. 
 
To further study if the ‘histaminergic pathway (PKA)’ is involved in the increased 
gastric acid secretion, the gastric glands were stimulated with adenylate cyclase activator, 
forskolin (5 µM).  Treatment of gastric glands with forskolin significantly increased ∆pH/min 
again to values similar in pdk1hm mice and in pdk1wt mice (Figure 26). Again, stimulation with 
forskolin was effective only in the pdk1wt mice as seen by the significant increase in pH 
recovery as compared to sham (0.1% DMSO treatment). On the other hand, the pH recovery 
in glands from pdk1hm mice was not significantly different between sham and forskolin 
treatment.  The difference between the genotypes however disappeared by the treatment with 
forskolin. 
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Figure 26: Effects of forskolin on pH recovery in parietal cells  
a. Original tracings illustrating alterations of pH in typical experiments in pdk1wt mice (left panels) and pdk1hm 
mice (right panels) in the absence (upper panels) and presence (lower panels) of forskolin (FSK, 5 µM). 
b. Arithmetic means ± SEM of Na+ independent alterations of cytosolic pH (∆pH/min) in parietal cells following 
an ammonium pulse in the absence (left bars) and presence (right bars) of forskolin (FSK, 5 µM) ) in gastric 
glands from pdk1hm mice (closed bars) and pdk1wt mice (open bars). * indicates significant difference between 
pdk1hm mice and pdk1wt mice, § indicates significant difference between absence (sham) and presence of 
forskolin. 
 
The glands were then treated with Protein kinase A inhibitor H89 (50 nM), in order to 
elucidate the role of cAMP dependent PKA in the increased gastric acid secretion in pdk1hm 
mice. H89 treatment resulted in the significant decrease in the ∆pH/min in pdk1hm mice but 
was without significant effect in pdk1wt mice. Thus the difference between the two genotypes 
was again abrogated by the H89 treatment of the gastric glands (Figure 27). 
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Figure 27: Effects of H89 on pH recovery in parietal cells  
a. Original tracings illustrating alterations of pH in typical experiments in pdk1wt mice (left panels) and pdk1hm 
mice (right panels) in the presence of PKA inhibitor H89 (H89, 50 nM). 
b. Arithmetic means ± SEM of Na+ independent alterations of cytosolic pH (∆pH/min) in parietal cells following 
an ammonium pulse in the presence of H89 (H89, 50 nM) in gastric glands from pdk1hm mice (closed bars) and 
pdk1wt mice (open bars). # indicates significant difference between absence (control, see Figure 24) and presence 
of H89. 
 
The gastric glands were further stimulated with carbachol (100 µM) to study if the 
cholinergic pathway is also involved in the increased acid secretion in pdk1hm mice. 
Carbachol significantly enhanced ∆pH/min in both pdk1hm mice and in pdk1wt mice again 
resulting in abrogation of the difference between pdk1hm and in pdk1wt mice (Figure 28). 
Carbachol enhanced the acid secretion in mice from both genotypes indicating that 
cholinergic pathway was still susceptible for stimulation and thus was not involved in the 
increased acid secretion in pdk1hm mice. 
 
 
Results                                                                                                                                  VIII 
 63 
∆
pH
u
n
its
/ m
in
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
#
#
a.
b.
pdk1+/+
pdk1hm
Time (minutes)
Na+NH4+ `0´ Na+ Na+ pHo `7´
7.5
6
6.5
7
8
1 10 20
carbachol
pH
u
n
its
Time (minutes)
Na+ NH4+ `0´ Na+ Na+ pHo `7´
6
6.5
7
7.5
1 10 20
carbachol
pH
u
n
its
pdk1+/+ pdk1hm
∆
pH
u
n
its
/ m
in
pH
u
n
its
pH
u
n
its
 
 
Figure 28: Effects of carbachol on pH recovery in parietal cells  
a. Original tracings illustrating alterations of pH in typical experiments in pdk1wt mice (left panels) and pdk1hm 
mice (right panels) in the presence of carbachol (100 µM). 
b. Arithmetic means ± SEM of Na+ independent alterations of cytosolic pH (∆pH/min) in parietal cells following 
an ammonium pulse in the presence of carbachol (100 µM) in gastric glands from pdk1hm mice (closed bars) and 
pdk1wt mice (open bars). # indicates significant difference between absence (control, see Figure 24) and presence 
of carbachol. 
 
To rule out the possibility of defective activation of protein kinase C in pdk1hm as a 
reason for increased gastric acid secretion, the glands were finally stimulated with activator of 
protein kinase C, phorbol 12 myristate 13 acetate (Phorbol ester, TPA) (100 nM) (69; 70). 
Stimulation of protein kinase C with Phorbol ester (TPA) enhanced ∆pH/min in pdk1hm mice 
and pdk1wt mice and ∆pH/min was again similar in pdk1hm and in pdk1wt mice (Figure 29). 
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Figure 29: Effects of phorbolester on pH recovery in parietal cells  
a. Original tracings illustrating alterations of pH in typical experiments in pdk1wt mice (left panels) and pdk1hm 
mice (right panels) in the presence of phorbolester, phorbol 12 myristate 13 acetate (TPA, 100 nM). 
b. Arithmetic means ± SEM of Na+ independent alterations of cytosolic pH (∆pH/min) in parietal cells following 
an ammonium pulse in the presence of phorbolester (TPA, 100 nM) in pdk1hm mice (closed bars) and pdk1wt mice 
(open bars). § indicates significant difference between absence (sham, see Figure 26) and presence of 
phorbolester. 
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Table 3: Effect of stimulators and inhibitors of gastric acid secretion on the rate of pH recovery, 
intracellular pH and buffer capacity in isolated gastric glands from PDK1 mice 
 
  
Rate of pH 
recovery (∆ pH 
units/ minute) 
Intracellular pH 
(units) 
Buffer capacity 
(mM/pH unit) 
Number of 
mice 
Number of 
cells 
pdk1wt 0.037 ± 0.005 7.16 ± 0.03 42.11 ± 5.83 15 156 Untreated 
(control) pdk1hm 0.090 ± 0.008 a 7.19 ± 0.02 37.93 ± 5.51 16 181 
pdk1wt 0.030 ± 0.009 7.15 ± 0.03 39.69 ± 4.75 5 41 Sham (0.1 % 
DMSO) pdk1hm 0.099 ± 0.027 a 7.18 ± 0.06 36.75 ± 6.51 4 72 
pdk1wt 0.009 ± 0.004b 7.19 ± 0.04 31.83 ± 2.22 3 30 
Omeprazole 
pdk1hm 0.011 ± 0.005b 7.15 ± 0.02 37.25 ± 18.60 3 50 
pdk1wt 0.296 ± 0.032b 7.21 ± 0.05 30.73 ± 3.60 6 98 
35 mM K+ 
pdk1hm 0.227 ± 0.025b 7.25 ± 0.02 35.33 ± 4.42 6 63 
pdk1wt 0.159 ± 0.021c 7.28 ± 0.03c 31.95 ± 3.74 6 65 
Forskolin 
pdk1hm 0.153 ± 0.026 7.25 ± 0.03 35.24 ± 4.02 6 71 
pdk1wt 0.028 ± 0.008 7.16 ± 0.06 44.65 ±8.85 5 61 
H89 
pdk1hm 0.044 ± 0.013b 7.10 ± 0.01b 49.79 ± 6.81 5 40 
pdk1wt 0.237 ± 0.046b 7.30 ± 0.08b 36.15 ± 8.26 5 57 
Carbachol 
pdk1hm 0.266 ± 0.050
b
 
 
7.27 ± 0.06 54.12 ± 12.83 5 49 
pdk1wt 0.209 ± 0.045c 7.24 ± 0.06 41.60 ± 7.96 5 61 
Phorbol ester 
pdk1hm 0.224 ± 0.014c 7.31 ± 0.03c 31.70 ± 5.50 5 51 
 
a - significant difference with respect to pdk+/+ mice. 
b - significant difference to respective control treatment. 
c - significant difference to respective sham treatment. 
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9 DISCUSSION 
 
i. Role of SGK1 in regulation of acid secretion 
 
a. Role of SGK1 in regulation of basal and stimulated acid secretion 
 
Serum and glucocorticoid inducible kinase 1 (SGK1) is potent regulator of KCNE1/KCNQ1 
trafficking and activity (51; 54; 71).  KCNQ1 channels are known to be upregulated by SGK1 
in the presence and absence of coexpressed KCNE1 (51). It can thus be assumed that the 
effect of SGK1 does not depend on KCNE1. SGK1 is partially effective through 
phosphorylation of Nedd4-2, which decreases the affinity of this ubiquitin ligase to its target 
proteins (72-75). SGK1 does apparently not affect the transcription of KCNQ1 but may be 
effective through increase of protein abundance in the cell membrane.  
 
 KCNQ1 is reported to play a critical role in the gastric acid secretion as seen by the 
complete absence of secretion in the KCNQ1 knock out mice (25; 28). Thus it is expected that 
absence of SGK1 would lead to decreased membrane abundance of KCNQ1 and thus 
impaired gastric acid secretion. However, pH recovery in the absence of Na+, an indicator of 
H+ secretion was similar in SGK1 knock out and wild type mice, clearly demonstrating that 
gastric acid secretion is absolutely normal in sgk1-/- mice. Moreover, even under conditions 
that are known to activate the classical pathways, the Na+-independent pH recovery is not 
different between the genotypes.  
 
 The apparently normal H+ secretion in the sgk1-/- mice raises the question which 
mechanism could replace SGK1 in regulating the membrane abundance of KCNQ1. 
Candidate kinases possibly replacing SGK1 include the isoforms SGK2 and SGK3 which 
have been cloned from homology screening (42)  and share the ability of SGK1 to enhance 
the protein abundance and/or activity of several channels and transporters (45). Experiments 
in Xenopus oocytes indeed disclosed the ability of SGK3 to up-regulate KCNE1/KCNQ1 
(51). 
  
The present observations thus indicate that SGK1 might not be trivial for the 
regulation of gastric acid secretion and its absence is possibly easily compensated. But 
nevertheless the importance of SGK1 in the regulation of membrane abundance of KCNQ1 
cannot be undermined. Therefore further experiments were aimed at exploring the effect of 
upregulation of SGK1 on the gastric acid secretion. 
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b. Role of SGK1 in glucocorticoid stimulation of acid secretion 
 
Treatment with corticosteroids is known to increase gastric acid secretion and thereby lead to 
ulcerations (2; 3). The present observations provide evidence for an involvement of SGK1 in 
the corticosteroid induced gastric acid secretion.  
 
 At least in theory, SGK1 could enhance H+ secretion by stimulating KCNQ1 channels, 
which are required for recycling of K+ into the lumen (25; 28). The K+ recycling provides the 
H+/K+-ATPase with luminal K+ and the KCNQ1 channels are thus critically important for 
gastric H+ secretion (25; 28). 
 The critical role of K+ channels is suggested by the potent stimulation of pH recovery 
following increase in extracellular K+ concentration to 35 mM. The increase of extracellular 
K+ concentration may enhance luminal K+ concentration by depolarization of the basolateral 
cell membrane and through circular current of the apical cell membrane with subsequent 
activation of apical KCNQ1. In any case those experiments suggest that under the 
experimental conditions extracellular K+ concentration is indeed limiting for H+/K+-ATPase 
activity. SGK1 dependent upregulation of KCNQ1 channels would accelerate K+ recycling 
into the lumen and thus provide the H+/K+-ATPase with K+.  
 
 Notably, prior to treatment with dexamethasone, the acid secretion is similar in SGK1 
knockout animals (sgk1-/-) and their wild type littermates (sgk1+/+). Moreover, the effect of 
carbachol and forskolin is similar in sgk1-/- and sgk1+/+ mice. Thus, stimulation of protein 
kinase A apparently overrides the lack of SGK1. Under our experimental conditions the role 
of SGK1 becomes apparent only after stimulation with the glucocorticoid dexamethasone. 
 
 Basal corticosterone levels at the beginning of the light cycle were similar in sgk1+/+ 
and sgk1-/- mice. However, sgk1-/- showed significantly higher peak corticosterone levels 
which were suppressible to the same extent as in sgk1+/+ mice by dexamethasone treatment. 
The increased peak corticosterone levels of sgk1-/- mice does, however, not translate into an 
enhanced basal gastric acid secretion, again pointing to a blunted glucocorticoid sensitivity of 
gastric acid secretion in those mice.  
 
 In conclusion, in the absence of glucocorticoids little differences are observed between 
sgk1-/- and sgk1+/+ mice in gastric H+ secretion. Thus, basal H+ secretion does not depend on 
SGK1. However, the glucocorticoid induced stimulation of H+ secretion is at least partially 
dependent on SGK1 and upregulation of SGK1 could possibly lead to increased gastric acid 
secretion. 
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c. Role of SGK1 in peroxisome proliferator activated receptor gamma 
(PPARγ) agonist mediated stimulation of acid secretion 
 
The present observations disclose a stimulating effect of pioglitazone on gastric acid 
secretion. Pioglitazone treatment increased gastric expression of the serum and glucocorticoid 
inducible kinase SGK1, which obviously accounts for this side effect of the PPARγ agonist.  
 
As shown previously (56), sgk1+/+ and sgk1-/- mice do not differ in PPARγ expression 
or pioglitazone plasma levels. The latter were in the lower micromolar range (10-15 µM), 
which is comparable to levels measured in volunteers after oral ingestion of 30 mg 
pioglitazone (3 µM, (76)). At those concentrations, pioglitazone does increase extracellular 
fluid volume, as previously shown for PPARγ agonists (77-79). 
The stimulation of gastric acid secretion by pioglitazone requires the H+/K+-ATPase, 
as it is abrogated in the presence of H+/K+-ATPase blocker omeprazole. Interestingly, 
pioglitazone treatment leads to increased colocalization of the proton pump H+/K+-ATPase 
and the potassium channel KCNQ1 in both genotypes, but the membrane translocation of the 
vesicles containing the channel and the pump is seen only in SGK1 wild type mice. Thus, 
SGK1 does not play a role in the colocalization but is mainly important for the trafficking of 
the vesicles towards the membrane. H+ secretion is markedly enhanced following an increase 
in extracellular K+ concentration and the difference between sgk1+/+ and sgk1-/- mice and 
between untreated and pioglitazone treated mice from either genotype is dissipated. This 
finding again supports the view that stimulation of gastric acid secretion is at least in part by 
enhancement of K+ recycling.  
 
Previous experiments have shown that glucocorticoids stimulate gastric acid secretion 
by a mechanism similarly sensitive to extracellular K+ concentration and at least in part 
through the serum and glucocorticoid inducible kinase SGK1. Along those lines, the 
stimulation of gastric acid secretion by dexamethasone is inhibited by blockage of 
phosphatidylinositol PI-3 kinase, a kinase upstream of SGK1 (80). 
 
Stimulation of gastric acid secretion would be expected to favour the formation of 
gastric ulcers. However, PPARγ agonists have been reported to foster ulcer healing (81) and 
protect against gastric ischemia-reperfusion damage (82). Possibly, the stimulating effect on 
gastric acid secretion is overridden by the simultaneous stimulating effect on trefoil factor 
expression (83), which are known to exert protective effects (84). 
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In conclusion, PPARγ agonists upregulate the gastric expression of SGK1, which in 
turn stimulates gastric acid secretion. The effect adds to the known side effects of those 
clinically valuable drugs.  
 
d. SGK1 dependant stimulation of gastric acid secretion in mutant apc 
mice (apcMin/+) 
 
The present observations provide evidence for involvement of ‘wnt’ signalling in the stomach. 
Na+-independent omeprazole-sensitive realkalinization of gastric gland cells following an 
ammonium pulse was significantly more rapid in heterozygous mice with defective APC 
(apcMin/+) than in their wild type littermates (apc+/+). Accordingly, in the absence of 
stimulation, H+/K+-ATPase activity was about two fold as fast in apcMin/+ mice as in apc+/+ 
mice. Notably, the marked difference is observed between heterozygous and wild type mice. 
Thus, the moderate decrease of APC expression in heterozygous mice is sufficient to 
substantially modify gastric acid secretion.  
 
 The results presumably do not reflect a direct stimulation of H+/K+-ATPase activity. 
Instead, APC deficiency could enhance H+ secretion more indirectly by upregulation of SGK1 
which inturn is shown to enhance K+ recycling through KCNQ1 channels (51; 54; 71). The K+ 
recycling from the cell into the lumen provides the H+/K+-ATPase with luminal K+ and is thus 
critically important for gastric H+ secretion (25; 28). Accordingly, an increase in the 
extracellular K+ concentration leads to marked increase in H+/K+-ATPase activity. Under 
those conditions, the extracellular K+ concentration is no more limiting for H+/K+-ATPase 
activity. The disappearance of the difference between apcMin/+ mice and apc+/+ mice at 
enhanced extracellular K+ concentration supports an effect of APC on K+ recycling. Previous 
experiments in SGK1 mice have shown that glucocorticoids and pioglitazone stimulate gastric 
acid secretion by a mechanism similarly sensitive to extracellular K+ concentration.  
 
Western blotting and quantitative real time PCR experiments indeed disclosed higher 
SGK1 expression levels in gastric glands from apcMin/+ mice than in those from apc+/+ mice. 
Most recently, SGK1 expression has been shown to be stimulated by ß-catenin through 
binding of TCF/β-catenin complexes to the SGK1 promoter (67). As a matter of fact ß-catenin 
expression is similarly higher in apcMin/+ than in apc+/+ gastric glands and immunochemistry 
reveals enhanced KCNQ1 protein abundance in the plasma membrane of parietal cells.  
 
Discussion                                                                                                                             IX 
 70 
 The difference between apcMin/+ mice and apc+/+ mice was further dissipated by prior 
treatment with forskolin, which leads to stimulation of protein kinase A (PKA) and, similar to 
SGK1, to upregulation of KCNQ1 activity (85-87). Apparently, similar to SGK1, protein 
kinase A increases KCNQ1 trafficking to the cell membrane.  
 
Furthermore, the central role of SGK1 is clearly demonstrated by the experiments 
conducted in the apcMin/+ mice lacking addionally SGK1. The additional knock out of SGK1 
in the apcMin/+ mice led to abrogation of enhanced gastric acid secretion in these mice and the 
H+/K+-ATPase activity was comparable to that of apc+/+ mice thus indicating that 
upregulation of SGK1 due to abnormal ‘wnt’ signalling is responsible for increased gastric 
acid secretion in the respective mice. 
 
 In conclusion, basal gastric acid secretion is markedly increased in mice carrying the 
defective APC gene and the present studies suggest the upregulation of SGK1 as the possible 
reason for the observed effect.  
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ii. Role of PDK1 in regulation of acid secretion  
 
The present observations provide evidence for an involvement of phosphoinositide dependent 
kinase 1 (PDK1) in the regulation of gastric acid secretion and underscore the conclusions of 
the previous study suggesting that gastric acid secretion is suppressed by phosphoinositide 3 
kinase (PI3K) dependent signalling (57). Moreover, these experiments define the PI3K 
dependent pathway involved. PI3K is apparently effective through PDK1, which activates the 
serum and glucocorticoid inducible kinase (SGK) or protein kinase B (PKB/Akt) isoforms 
(41; 52; 88-93). 
 The present study did not attempt to define the PDK1 dependent signalling, which 
may involve any of the SGK or PKB/Akt isoforms. In the previous study, pharmacological 
PI3K inhibition disrupted the phosphorylation of PKB/Akt, a finding suggesting that 
PKB/Akt could have been the downstream target of PI3K signalling (57). According to the 
previous observations, the basal gastric acid secretion is not significantly altered by genetic 
knockout of SGK1. Thus, defective activation of SGK1 hardly accounts for the observed 
stimulation of basal gastric acid secretion in the PDK1 deficient mouse or following 
pharmacological PI3K inhibition.  
 
 The present observations further demonstrate that increase of extracellular K+ 
concentration enhances gastric acid secretion to a greater extent in wild type mice (pdk1wt) 
than in PDK1 hypomorphic mice (pdk1hm). Accordingly, the increase of extracellular K+ 
concentration abrogated the differences between the genotypes. Although the difference did 
not reach statistical significance, the experiment did demonstrate that PDK1 dependent 
signalling influences gastric acid secretion by affecting the availability of luminal K+ for the 
H+/K+-ATPase. In presence of surplus K+ ions in the canaliculus, availability of K+ ions for 
exchange is no more a rate limiting step and thus H+ ion secretion is no longer dependant on 
the activity of K+ channels. Therefore glands from pdk1wt mice showed faster recovery values 
as compared to pdk1hm mice.  
 
 The recycling of K+ from the cell into the lumen is accomplished by KCNQ1 channels, 
which indeed play a decisive role in gastric acid secretion (25; 28). The channels are activated 
not only by SGK1 (51; 54; 71), but also by protein kinase A (94-97). 
Previous studies indicated the negative regulation of cellular cAMP levels by PI3K 
signalling and accordingly inhibition of PI3-kinase signalling lead to increased of cellular 
cAMP levels and eventually to enhanced activation of protein kinase A (46; 47). More 
importantly this mechanism was shown to be effective in the parietal cells as seen by the 
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increased gastric acid secretion in the wortmannin and LY294002 (PI3 kinase inhibitors) 
treated cells (57). Accordingly, the protein kinase A inhibitor H89 substantially decreased the 
gastric acid secretion in pdk1hm mice. Inhibitory effect of H89 on the acid secretion only in 
pdk1hm mice clearly confirms the role of the cAMP dependent PKA in the increased gastric 
acid secretion. 
 
Conversely, activation of protein kinase A by forskolin stimulated gastric acid 
secretion only in pdk1wt mice suggest that PKA is already active in pdk1hm mice and could not 
be further activated. Both, H89 and forskolin virtually abolished the differences of gastric acid 
secretion between the genotypes.  
 
Carbachol enhanced the acid secretion in mice from both genotypes indicating that 
cholinergic pathway was still susceptible for stimulation and thus was not involved in the 
increased acid secretion in pdk1hm mice. Similarly stimulation of gastric acid secretion by 
phorbol esters in both the genotypes indicates that PKC is not involved in the enhanced 
gastric acid secretion in pdk1hm mice. 
 
 In conclusion, basal gastric acid secretion is significantly stronger in pdk1hm than in 
pdk1wt mice. Thus, PDK1 exerts an inhibitory action on basal gastric acid secretion. 
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10 ABBREVIATIONS  
 
ADP  Adenosine Di Phosphate  
AMP  Adenosine Mono Phosphate  
APC  Adenomatous polyposis coli 
ATP  Adenosine Tri Phosphate  
Ach  Acetyl choline 
µg  Microgram  
µl  Microliter  
µM  Micromolar  
CCK2  Cholecystochinin type 2 receptor 
Bw  Body weight  
BSA       Bovine serum albumin  
cAMP      Cyclic Adenosine Mono phosphate  
CCH  Carbachol 
cDNA      complementary Deoxyribonucleic Acid  
cRNA       complementary Ribonucleic Acid  
DMSO       Dimethylsulfoxide  
DNA       Deoxyribonucleic Acid  
dNTP       Deoxyribo-Nucleotidetriphosphate  
DEX       Dexamethasone  
ECL cells Enterochromaffin-like cells 
EDTA      Ethylenediamine tetraacetic acid  
ELISA      Enzyme-Linked Immunoabsorbent Assay  
ENaC       Epithelial sodium channel   
FSK  Forskolin 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GLUT1 / 4     Glucose Transporter isoforms 1 /4  
GRP  Gastrin releasing peptide 
H2  Histamine type 2 receptor 
HEPES     N-(2-Hydroxyethyl) piperazine-N-(2-ethanesulfonic acid)  
IGF1       Insulin- like growth factor 1 
Min  Multiple intestinal neoplasms 
Nedd4-2     Neuronal cell expressed developmentally down regulated 4-2  
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NHE3       Na/H-exchanger isoform 3  
NMDG     N-methyl-D-glucamine  
◦ C         Degree(s) Celsius (centigrade)  
PBS        Phosphate Buffered Saline  
PCR       Polymerase chain reaction 
PDK1       Phosphoinositide-dependent kinase isoform 1  
PFA        Paraformaldehyde   
PI3K       Phosphatidyl- inositol -3-kinase  
PKA          Protein Kinase A  
PKB (Akt)      Protein Kinase B; oncogene from Akt mouse  
PKC       Protein Kinase C  
kDa       Kilo Dalton   
Ringer      Buffer Solution  
ROMK     Renal outer medullary K+ channel   
SEM     Standard Error of Mean 
SGKs       Serum and Glucocorticoid inducible protein Kinase isoforms  
SGLT        Sodium-glucose cotransporter  
SSRT2  Somatostatin receptor type 2 
TPA  Phorbol 12 myristate 13 acetate (phorbol ester) 
TRIS       Tris (hydroxymethyl) aminomethane   
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